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Necrotic enteritis (NE), a devastating enteric disease caused by Clostridium
perfringens type A, contributes to the losses of 6 billion dollars worldwide per year and is
currently being considered as a major global threat to the poultry industry. In past
decades, it has been well-controlled by in-feed antimicrobial growth promoters (AGPs).
The withdrawal of AGPs due to antibiotic-resistance concerns resulted in a spike in NE
incidence and led to the re-emergence of NE in the modern broiler production system.
To unveil the association of toxin genes of C. perfringens, particularly for netB,
with clinical NE, a self-designed qPCR primer set targeting netB was developed to
qualify and quantify netB in NE-producing and non-NE-producing isolates. The netB was
demonstrated to exist in the majority of C. perfringens type A isolates. The presence and
the amount of netB were not significantly different between two types of isolate,
indicating that those indicators are insufﬁcient to predict an association with the
pathogenicity of NE. The virulence of netB is suggested to be expressed or triggered
under certain conditions, further promoting NE.

A side by side trial was implemented with different combinations of netB-positive
C. perfringens (CP1) and two predisposing factors to assess their role in NE
development. Both CP1 and predisposing factor(s) are required for consistent NE
reproduction, and particularly, Eimeria exerts significant effects on NE induction. The
use of CP1 without a predisposing factor failed to induce NE. The severity and incidence
of NE were positively correlated with the number of predisposing factors given in the NE
induction.
Analyzing gut microbiota in chickens challenged with CP1 and/or Eimeria by
metagenomic sequencing, significant overgrowth of Clostridium sensu stricto 1, the
genus contains C. perfringens, was associated with NE. Eimeria infection precedent to
CP1 challenge had a synergistic effect on the overrepresentation. In addition to C.
perfringens, the other member under Clostridium sensu stricto 1 was found to participate
in NE development. Given supplementary dose of 0.4 kg/ton in feed, lauric acid neither
exerted the inhibitory effect against proliferation of Clostridium sensu stricto 1 and C.
perfringens nor reduced the incidence and severity of NE.
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CHAPTER I
INTRODUCTION
1.1

Clostridium perfringens
Clostridium perfringens (C. perfringens) is a Gram-positive, spore-forming

anaerobe that is widely distributed in the environment, as well as a commensal in the
intestines of humans and animals (Timbermont et al., 2009). It belongs to the Genus
Clostridium, Family Clostridiaceae, Order Clostridiales, and Class Clostridia (KetoTimonen et al., 2006) in the Phylum Firmicutes that is associated with gastrointestinal
(GI) diseases (Uzal, 2016). The ability to form endospores supports this bacterium to
survive adverse conditions for long periods of time, in turn, transmit the host (Novak et
al., 2003). In addition, C. perfringens can produce at least 17 toxins and extracellular
enzymes that have specific activities and roles in the disease process (Freedman et al.,
2015; Rood, 1998; Uzal et al., 2014). Analysis of its genome revealed that C. perfringens
lacks genes essential for 13 amino acid biosynthesis, but it acquires those nutrients from
hosts through various actions of toxins and enzymes (Myers et al., 2006; Shimizu et al.,
2002). Therefore, it is characterized as a versatile enteric pathogen that rapidly destroys
tissues, uptakes nutrients and proliferates in the hosts (Shimizu et al., 2002; Songer,
1996).
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1.2

Toxinotypes and toxins produced by C. perfringens
Among produced toxins, α (alpha), β (beta), ε (epsilon), and ι (iota) four toxins

are designated as major toxins due to the toxinotyping classification system of C.
perfringens, which classifies C. perfringens isolates into A, B, C, D, and E toxinotypes
(Van Immerseel et al., 2004b). Other toxins are constantly termed minor toxins and
nonetheless critical to the virulence of C. perfringens (Table 1.1). The toxin production
varies in type from type and strain from strain. For the major toxins, type A only
produces alpha toxin. However, type B generates alpha, beta, and epsilon toxins, type C
has alpha and beta toxins, type D produces alpha and epsilon toxins, and type E possesses
alpha and iota toxins. Regarding the minor toxins, all toxinotypes may carry the cpe and
cpb2 genes that encode enterotoxin (CPE) and the β2/beta 2 (CPB2) toxins, respectively
(Gibert et al., 1997; Songer, 1996). In contrast, necrotic enteritis B-like (NetB) toxin is
only found in type A strains (Keyburn et al., 2008; Keyburn et al., 2010). The production
of toxin perfringens large (TpeL) toxin has been demonstrated in types A, B, and C
(Coursodon et al., 2012; Li et al., 2013; Nakano et al., 2017).
Table 1.1
Toxin
Alpha
Beta
Epsilon
Iota
Enterotoxin
Beta2
NetB
TpeL

Toxinotypes and produced toxins of C. perfringens
Gene
cpa
cpb
etx
iap
cpe
cpb2
netB
tpeL

A
+
+/+/+/+/-

B
+
+
+
+/+/+

2

Toxinotype
C
+
+
+/+/+/-

D
+
+
+/+/-

E
+
+
+/+/-

1.3

Virulence factors of C. perfringens
The virulence of C. perfringens is mediated by its intimidating arsenal of toxins

and degradative enzymes. (Petit et al., 1999; Prescott et al., 2016a; Uzal et al., 2014).
Previous studies demonstrated the essentiality of alpha toxin (CPA) to the pathogenicity
of gas gangrene caused by type A strain (Awad et al., 1995), necessity of beta toxin
(CBP) to the development of enteric disease caused by type C (Sayeed et al., 2008),
epsilon toxin (ETX) for type D isolates to promote enterotoxemia in sheep and goats
(Uzal et al., 2014), and enterotoxin (CPE) to be the determinant virulence of human food
poisoning and non-foodborne GI infection (Sarker et al., 1999). In the case of necrotic
enteritis (NE), the role of toxins in the virulence of clinical NE remains controversial. In
the past, CPA toxin was initially recognized as the key virulence factor. However, it lost
the role in pathogenicity owing that a toxin null mutant constructed in NE strains retained
full virulence during the experimental challenge (Keyburn et al., 2006). Afterward, the
NetB toxin was demonstrated to contribute to the main virulence of C. perfringens in NE
based on in vivo evidence that disease development was achieved with the participation
of a wild-type strain with netB or a complemented netB strain, but not in null mutant
strain (Keyburn et al., 2008). Despite CPB2 having not been associated with NE in
broiler chickens (Crespo et al., 2007; Gholamiandekhordi et al., 2006), a study in the
Netherlands suggested that cpb2 might be involved in subclinical NE in laying hens
(Allaart et al., 2012). Furthermore, TpeL toxin and perfrin were also demonstrated as
important factors to enhance the virulence in NE (Chen and McClane, 2015; Coursodon
et al., 2012; Timbermont et al., 2014).
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The pathogenesis of a bacterial infection that regularly involves the participation
of colonization, multiplication, nutrient acquisition, host evasion, damage, and
transmission is dynamic and reasonably simultaneous (Prescott et al., 2016a). Therefore,
factors that influence the process of disease development are also considered to have
significant contributions to the virulence. Several studies suggested that bacitracin,
chitinase, collagenolytic enzymes, and sialidase were associated with the virulence of C.
perfringens and proposed that those act synergistically with toxins. Bacitracin generally
inhibits the growth of closely related strains to promote single-strain dominance of
pathogenic C. perfringens in diseased birds (Timbermont et al., 2014; Timbermont et al.,
2011). Chitinases, a member of the glycoside hydrolases (GHs) family that are bacterial
endoglycosidases hydrolyze the chitobiose core of N-linked glycoproteins, are involved
in mucus colonization and degradation (Lepp et al., 2010; Prescott et al., 2016a).
Collagenolytic enzymes cause the epithelial damage of the intestinal mucosa to initiate
the pathological progress of NE (Olkowski et al., 2008). Sialidase catalyzes the sialic acid
hydrolysis from the host cell membrane, exposing β-galactosyl determinant which acts in
the adherence process among clostridia and the host mucosa, facilitating its attachment to
the mucosa (Li and McClane, 2014; Llanco et al., 2015).
Since the contribution of netB to the virulence has been demonstrated to fulfill the
molecular Koch's postulates (Keyburn et al., 2008), current studies continue to emphasize
the importance of NetB toxin in the NE development. Nevertheless, several lines of
evidence evoked the controversy that full virulence resulted from the expression of netB.
Firstly, the discovery of netB was documented not merely in NE-producing C.
perfringens, but also in C. perfringens isolates from healthy chickens, cattle (Martin and
4

Smyth, 2009) and human (Nakano et al., 2017). In addition, a proportion of C.
perfringens strains isolated from healthy chickens showed the carriage of netB with some
degree of in vitro NetB toxin production but did not induce NE (Abildgaard et al., 2010;
Chalmers et al., 2008; Martin and Smyth, 2009). Moreover, a number of NE cases in
broilers, which C. perfringens isolates were negative for the netB gene (Abildgaard et al.,
2010; Bailey et al., 2015; Llanco et al., 2015; Martin and Smyth, 2009; Smyth and
Martin, 2010). Lastly, use of C. perfringens harboring netB in the absence of other genes
on the plasmid-encoded pathogenicity locus (NELoc-1) failed to restore full virulence of
NE in the experimental model, suggesting that other genes present at NELoc-1 are
required during NE pathogenesis in a role not related to NetB expression (Zhou et al.,
2017). A number of genes with putative virulence-related functions were indicated,
including adhesins, glycosidases, and a cyclic-di-GMP signaling system (Lepp et al.,
2010). Those contradictory findings revealed that other factors may be involved in the
NE development, not mainly depending on netB.
1.4

C. perfringens-associated illness in humans
C. perfringens type A is recognized as one of the major foodborne pathogens in

humans (Petit et al., 1999). The pathogenicity are attributable to enterotoxin (CPE)
encoded by cpe. The CPE-producing C. perfringens was estimated to cause 1 million
illnesses each year in the United States (Batz et al., 2012; CDC 2017; Scallan et al.,
2011). Beef, poultry, and pork are common sources of these infections (Grass et al.,
2013) and the outbreaks are typically associated with improper cooling or inadequate
reheating of contaminated meats (Schlundt 2015). However, the most important animal or
environmental reservoirs for CPE-producing C. perfringens remains unknown (McClane,
5

2007). In addition to human food poisoning, CPE-producing C. perfringens also
contributes to 5-15% of non-foodborne GI diseases in human, including antibioticassociated diarrhea and sporadic diarrhea (Carman, 1997). CPE has been demonstrated
essential for enterotoxicity in both foodborne and non-foodborne human illnesses (Sarker
et al., 1999). Expression of CPE toxin occurs during sporulation of C. perfringens in the
intestines (Navarro et al., 2018). The cpe encoding CPE was found able to locate either
on a chromosome or on a plasmid (Freedman et al., 2016). The majority of food
poisoning strains carry a chromosomal copy, whereas other non-foodborne strains harbor
a plasmid-borne gene (Grant et al., 2008). A study investigating the cpe gene in 2,659
isolates from animals, humans, and foods demonstrated that less than 5% of isolates carry
cpe gene (Daube et al., 1996). C. perfringens type A-associated enteric diseases are of
important concern to the poultry industry due to significant economic losses and the
potential risk of human food poisoning. Although the prevalence of cpe in C. perfringens
type A from poultry is rare, there were several food poisoning reports epidemiologically
traced back to chicken contaminated with C. perfringens type A (Hook et al., 1996;
Schiemann, 1977). The source of contaminations was unknown. These outbreaks were
correlated to deficiencies in hygiene and food preparation, but not directly linked to
chicken-origin cpe-positive C. perfringens. Therefore, the screening of cpe in chickenorigin C. perfringens isolates is continuously highlighted to provide a fundamental
database to evaluate the relationship of chicken-origin C. perfringens with food poisoning
in humans.
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1.5

Necrotic enteritis (NE)
NE is one of the important enteric diseases in broiler chickens, characterized by a

mass of necrosis and inflammation of small intestines, a significant decline in growth
performance, and an increase in mortality (Cooper et al., 2013; Martin and Smyth, 2009).
It regularly results in significant levels of mortality in clinical phase and/or loss of
productivity and poor feed conversion in subclinical manifestation. Up to 37% of
commercial broiler flocks could be affected and it contributed to the losses of 6.25 cents
per bird and 6 billion dollars to the global poultry industry (Van Der Sluis, 2000; Wade
and Keyburn., 2015). In-feed antimicrobial growth promoters (AGPs) and anti-coccidial
drugs, ionophores, were past effective approaches used to prevent and control C.
perfringens-associated NE in poultry (Liu et al., 2010). The AGPs aimed at controlling
the overgrowth of bacteria, whereas the ionophores prevented the damage to mucosa
caused by coccidiosis which predisposes chickens to the NE. However, phasing out of
those tools based on the rising concerns for the threat of spreading bacteria with antibiotic
resistance from animals to humans had spiked incidence of the disease and promoted NE
as re-emerging disease in the poultry industry (Casewell et al., 2003; Gaucher et al.,
2015; Timbermont et al., 2011; Van Immerseel et al., 2009). Accordingly, the industry is
seeking alternative interventions or strategies for the control of this economically
significant disease.
1.5.1

Etiology and host range
C. perfringens types A (rarely type C) is the causative agent of NE. A higher

amount of this bacterium is associated with the appearance of necrotic lesions in the
jejunum of affected birds (Paiva and McElroy, 2014). Owing to the nature of its ubiquity
7

(Craven, 2000; Van Immerseel et al., 2004b), it is considered that the participation of
other contributing factors are required for disease development. Typically, outbreaks of
NE in poultry are sporadic (Cooper et al., 2016). Chickens aged from 2 weeks to 6
months are susceptible to NE, and this disease ordinarily affects broiler flocks raised on
the litter between 2 to 6 weeks of age due to a window in the chick’s anti-clostridial
immunity (La Ragione and Woodward, 2003). The disease usually persists in a flock for
5 to 10 days (Merck Veterinary Manual, 1998). Mortality rates are between 2% and 10%
in the acute phase; however, rates as high as 50% have been reported (Paiva and
McElroy, 2014). Two forms of NE are noted in the field. Clinical or named as an acute
form of NE has typical signs, including severe depression, reluctance to move, ruffled
feathers, diarrhea, huddling, anorexia, and high mortality. The progress of clinical illness
is often acute, with birds dying within 1 to 2 hours after the onset of clinical signs.
However, the subclinical form of NE affects chickens without premonitory symptoms,
leading to decreased feed conversion rates and poor growth performance which
contributes to main economic losses to the poultry industry. NE has also been reported in
3 to 6-month-old commercial layers and in 12 to 16 week-old replacement pullets. In
addition, a wide variety of avian species could be affected as well, including turkeys,
ostriches, quails, capercaillies, geese, bluebirds, lorikeets, and crows (Cooper et al.,
2013).
1.5.2

Epidemiology
The occurrence of NE varied in different temporal and spatial sequence. A cross-

sectional survey of 857 broiler farms in the UK indicated a prevalence rate in the recently
reared flock was at 12.3% (Hermans and Morgan, 2007). The disease can occur more
8

than once a year on any particular farm. Univariate analysis showed numerous factors
associated with the occurrence of NE, such as the existence of other diseases,
environments, husbandry, hygiene and biosecurity, feed and feeding, the use of
preventative or curative treatments, and flock performance (p ≤ 0.05) (Hermans and
Morgan, 2007). Multilevel logistic regression demonstrated strong associations between
NE and the occurrence of wet litter and coccidiosis (Hermans and Morgan, 2007). The
use of disinfectant containing ammonia against coccidial oocysts was an independent risk
factor. In addition, the positive association between NE and the use of plasterboard walls
in poultry houses indicated an important role of cleaning and disinfection in the
epidemiology of this disease (Hermans and Morgan, 2007). However, a subclinical form
of NE regularly goes unobserved. It is difficult to depict the exact sense of the
epidemiology of subclinical form.
1.5.3

Pathogenesis
The occurrence of clostridial enteritis is primarily correlated with the proliferation

of Clostridia in the intestinal tract, which is followed by the incremental production of
toxins (Theoret et al., 2016). In the case of NE, the disease starts when C. perfringens
proliferates anarchically in the small intestine of chickens, producing toxins that cause
necrosis (Cooper et al., 2016). During the initial disease development, C. perfringensgenerated bacteriocins to inhibit the growth of other C. perfringens populations,
particularly for isolates from healthy birds, allowing NE-producing strain to be dominant
(Timbermont et al., 2014; Timbermont et al., 2011). Simultaneously, this strain harbors
attachment factors to efficiently adhere to extracellular matrix molecules to perform the
colonization. In addition, proteolytic enzymes produced by NE strain affect basement
9

membrane of the villous enterocytes to establish initial infection. By achieving single
dominance, filling open niches, and securing invasion in the host, toxins secreted by C.
perfringens exert their enterotoxicity in the small intestines (Bailey et al., 2015; Keyburn
et al., 2008; Li et al., 2011).
1.5.4

Predisposing factors
The ubiquitous nature renders C. perfringens unable to develop the disease

without other factors (Craven, 2000; Van Immerseel et al., 2004b). Experimentally, a
variety of predisposing factors have been unveiled to promote the onset and development
of NE by contributing to the colonization, overgrowth, and infection of C. perfringens,
including parasites (Eimeria spp.), dietary factors (high level of protein or non-starch
polysaccharides in diet), immunosuppressive diseases (Infectious Bursal Disease,
Chicken Infectious Anemia, Marek’s Disease), mycotoxin, host genetics, high stock
density, and low temperature (Lee et al., 2011; Park et al., 2008; Prescott et al., 2016b;
Thompson et al., 2006; Williams, 2005; Williams et al., 2003).
1.5.4.1

Coccidiosis
Coccidiosis is a parasitic disease in poultry caused by pathogenic Eimeria spp.

These parasites colonize the small intestine and cause extensive damage to the intestinal
mucosa as a consequence in their lifecycle (Williams, 2005). A preceding or co-infection
with Eimeria targeting the small intestine is demonstrated as a major contributor to NE in
chickens. They have multiple effects that promote NE development. For instance,
physical damages to the gut epithelium facilitate the colonization and proliferation of C.
perfringens (Van Immerseel et al., 2009; Williams, 2005; Williams et al., 2003). The
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intestinal lumen then becomes rich with plasma proteins that serve as growth substrates
for C. perfringens (Van Immerseel et al., 2004b). In addition, reduced digestibility due to
extensive gastrointestinal damage substantially also increases nutrient availability for the
growth of C. perfringens. Moreover, coccidiosis induces a T-cell-mediated inflammatory
response that enhances mucin production, which is beneficial for the overgrowth of C.
perfringens due to its ability to utilize mucus as a substrate (Collier et al., 2008).
1.5.4.2

Diets
Diets enriched with cereals (wheat, rye, barley, or oats) or high level of proteins

such as fishmeal has been demonstrated as predisposing factors affecting the onset of NE.
(Cooper and Songer, 2009; McDevitt et al., 2007; Williams, 2005). It was suggested that
cereals (barley, rye, oats, and wheat) containing high levels of indigestible, water-soluble,
non-starch polysaccharides (NSP) increased the viscosity of the digesta and hence slowed
transit time in the gut (Annett et al., 2002; Langhout et al., 1999). NSP could also leave
undigested nutrients available for microbial proliferation (Choct and Annison, 2007),
change the mucosal architecture, and increased the number of intestinal goblet cells per
crypt to elevate mucin production (Kleessen et al., 2003), thus promoting the overgrowth
of C. perfringens (Shojadoost et al., 2012). High animal protein diets, especially those
supplemented with fishmeal, provide high levels of available nutrients, such as specific
amino acids that C. perfringens is unable to synthesize itself, subsequently improving its
growth (Drew et al., 2004; Titball et al., 1999). Furthermore, the addition of fishmeal in
the diet can increase intestinal pH, favoring the proliferation of C. perfringens (McDevitt
et al., 2007), destabilize and alter the underlying gut microbial population, thus
predisposing chickens to develop NE (Stanley et al., 2012; Stanley et al., 2014b).
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1.5.4.3

Immunosuppression
Changes in the immune status of birds can increase the incidents of NE (Moore,

2016). Infectious bursal disease (IBD), chicken infectious anemia (CIA), and Marek’s
disease (MD) which have immunosuppressive effects in poultry (Hoerr, 2010) can
increase the severity of NE and promote the development of NE in the field
(Gholamiandehkordi et al., 2007; Stringfellow et al., 2009; Timbermont et al., 2009;
Williams et al., 2003) . Other stresses on chickens such as high stocking
density/overcrowding, heat or cold, environmental ammonia, and physiological stress
also may cause immunosuppression that exacerbates NE (Hoerr, 2010; Tsiouris et al.,
2015a, b).
1.5.4.4

Mycotoxin
Mycotoxins are secondary fungal metabolites naturally produced by a wide range

of fungi, primary molds in crops and feeds. Aflatoxins (AF), zearalenone (ZEN),
ochratoxin A (OTA), fumonisins (FUM), trichothecenes such as deoxynivalenol (DON),
and T-2 toxin are some of the mycotoxins that have the dramatic impact on the health and
productivity of poultry (Murugesan et al., 2015). Recently, DON was shown as a
predisposing factor for the development of NE, through damaging to the epithelial barrier
and increasing intestinal nutrient availability for the proliferation of C. perfringens
(Antonissen et al., 2014). Besides, another mycotoxin, FUM, produced by Fusarium
fungi was demonstrated to modify the composition of the intestinal microbiota of the
ileum and negatively affect the small intestinal length, ileal villus height, and crypt depth,
predisposing chickens to NE (Antonissen et al., 2015). Although the immunosuppression
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of mycotoxin was also suggested in affected chickens (Prescott et al., 2016b), the effect
needs to be further investigated.
1.5.4.5

Other factors
Host genetics were reported to exert some influence on susceptibility to NE that

certain breed of broilers appears to be more susceptible to NE in the field based on the
observations of body weight loss, greater gut lesion severity, and higher NetB antibody
levels (Jang et al., 2013). This difference of susceptibility may result from the difference
in immune responses to C. perfringens (Kim et al., 2014). In addition, a retrospective
study also showed the association of host genetics with a natural outbreak of NE in laying
hens. Large differences between major histocompatibility complex (MHC) genotypes
(genotype B21B21 being more resistant to NE compared to genotype B13B13) was noted in
relation to mortality and hen-day egg production in NE-afflicted laying hen flocks (Siegel
et al., 1993).
1.6

Gut microbiota and its role in enteric diseases
The chicken intestinal microbiota comprises various bacteria, methanogenic

archaea, fungi, and viruses (Yeoman et al., 2012). Microbial colonization varies along the
length of the gastrointestinal tract. Major taxa surveyed along the chicken gastrointestinal
tract (GIT) showed microbial density was 107 and 108 CFU/g in the gizzard with the main
species of bacteria being Lactobacilli. The bacterial density increased to between 108 and
109 in the small intestine with dominant bacteria that are Lactobacilli, Clostridia,
Escherichia and Enterococcus. At the distal intestine, the density increased to 1010 to
1012 and bacterial populations are Bacteroide, Fusibacteria, Coliforms, Lactobacilli,
13

Clostridia, etc. (Gong et al., 2002; Qu et al., 2008; Saengkerdsub et al., 2007a;
Saengkerdsub et al., 2007b). Among whole intestines, ceca are the site that has the most
microbial diversity and abundance in the intestines (Gong et al., 2007).
Gut microbiota has functions on the nutrient exchange, modulation of the immune
system, maintenance of the physiology of the digestive system, and the exclusion of
pathogens (Clavijo and Florez, 2018; Pan and Yu, 2014). Chicken gut microbiota
produces enzymes enabling the deconstruction of dietary polysaccharides (Beckmann et
al., 2006), and producing short-chain fatty acids (SCFAs). SCFAs are the primary energy
source of intestinal epithelia, essential to homeostasis of colonocytes and development of
villus morphology, and important to colonic musculature and vasculature in the GIT
(Yeoman et al., 2012). Germ-free birds have been found to possess shorter intestinal
villi, shallower crypts, and lower load of bacteria when compared to conventionallyraised birds (Forder et al., 2007; Gabriel et al., 2006). Additionally, gut microbiota has
been demonstrated to regulate intestinal gene expression (Yin et al., 2010) and T cellmediated immunity (Mwangi et al., 2010) as well as to accelerate the maturation of the
gut immune system (Crhanova et al., 2011). Healthy intestinal microbiota provides host
resistance to infection through their involvement in the development of the host immunity
and competitive exclusion to limit the colonization of pathogens (Rehman et al., 2007).
Hence, disruptions of the microbial community were suggested to alter host susceptibility
to infections and play a role in the development of enteric disease as well (Sekirov and
Finlay, 2009).
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1.7
1.7.1

Treatment and prevention of NE
Treatments
Treatment for NE greatly depends on antibiotics specifically designed to affect

gram-positive bacteria such as bacitracin, penicillin, virginiamycin, and lincomycin to
destroy clostridia and/or diminish bacterial populations in the intestines (Brennan et al.,
2001a; Brennan et al., 2001b; Hamdy et al., 1983). Traditionally, the poultry industry
used antimicrobial growth promoters (AGPs) in the feed to effectively treat and prevent
NE (Liu et al., 2010). However, the emergence of antibiotic-resistant bacteria from
animals and the potential threat of transmission to humans led to ban or limited use of
AGPs (Marshall and Levy, 2011; Van Immerseel et al., 2004b). Due to the withdrawal of
AGPs, NE has spiked the incidence and re-emerged in broiler production system
(Casewell et al., 2003; Gaucher et al., 2015; Timbermont et al., 2011; Van Immerseel et
al., 2009).
1.7.2

Measures to prevent and control NE
Recently, strategies for preventing NE are focusing on interventions that reduce

exposure to risk factors, boost immunity, avoid or decrease damage to the intestinal
mucosa, and inhibit the overgrowth of C. perfringens in the intestines (Brennan et al.,
2001a). Since NE has been often a secondary infection in a flock with a coccidial
infection, an effective control of coccidiosis is a reasonable way to significantly reduce
the risk of NE outbreaks. Coccidiostatic drugs and anticoccidial vaccines are usually
applied singly or together to limit the potential of coccidial exposure and provide
coccidial immunity (Li et al., 2004; Williams, 2002), subsequently preventing the
damage to the mucosa in the small intestines. Regarding induced immunity from NE
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vaccine, an effective protection against the disease has not been developed as of yet
(Alimolaei et al., 2018; Lillehoj et al., 2017; Mot et al., 2014; Thompson et al., 2006).
However, recent pieces of evidence indicate that mucosal immune responses are crucial
for the protection and multiple antigens are required for promoting the essential immunity
(Jiang et al., 2015; Mot et al., 2014). To avoid mucosal damage and multiplication of C.
perfringens, alternations to feed composition by removing NSP and high level of proteins
have been shown some effects on NE reduction (Shawkat A. M'Sadeq, 2015). Addition
of exogenous enzymes in wheat-based diets also can significantly decrease digesta
viscosity in the small intestine, which in turn reduce the number of nutrients available to
the bacterial growth (Choct et al., 1999).
Although several strategies have been developed to prevent and control NE, none
of them provided the desirable or consistent protection against NE as AGPs did before.
Hence, the poultry industry is still seeking for alternative supplements in the feed to
replace AGPs. Probiotics, prebiotics, organic acids, various plant extracts such as
essential oils, and feed enzymes were examined and demonstrated the different degree of
effects on the reduction of NE (Caly et al., 2015; Dahiya et al., 2006).
1.7.2.1

Probiotics
Probiotics, defined as live microbial feed supplements, have been demonstrated to

benefit chickens by improving immunity and intestinal morphology, stimulating the
metabolism, producing molecules with antimicrobial activities (e.g. bacteriocins),
inhibiting the adhesion of pathogens and the production of pathogenic toxins, or
competing against pathogenic strains within the host (Caly et al., 2015; Pan and Yu,
2014). Different supplemented bacteria showed variable effects. For instance,
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Lactobacillus agilis and Lactobacillus salivarus have the ability to stimulate the butyrateproducing microbiota and to re-establish the balance of microbiota (Meimandipour et al.,
2009). Bacteria of the genera Bifidobacterium and Lactobacillus help to reduce adhesion
of pathogenic microorganisms such as Salmonella, Enterobacter sakasaki, and
Clostridum difficile (Collado et al., 2005; Servin and Coconnier, 2003). However, the
effectiveness of probiotics is controversial with positive effects in some studies while
intangible results in others (Clavijo and Florez, 2018). Accordingly, more studies are
suggested to evaluate the significance of these applications on NE reduction.
1.7.2.2

Prebiotics
Prebiotics are non-digestible feed ingredients that selectively affect the host by

stimulating growth or activity of beneficial flora in the intestine (Gibson and Roberfroid,
1995). The aim of using prebiotic is to stimulate acidolactic and bifidogenic bacteria in
GIT. Their functions include attachment to pathogens to prevent colonization, the
increment of luminal osmosis, being substrates for fermentation, indirect stimulation of
macrophages and production of SCFAs, and immune modulation (Patel and Goyal,
2012). Several studies in chickens showed pieces of evidence that fructo-oligosaccharides
(FOS) and manno-oligosaccharides (MOS) had positive effects on inhibition of
Salmonella and E. coli (Chambers and Gong, 2011; Stanley et al., 2014a). In the case of
the NE, dietary supplementation with MOS decreased the abundance of C. perfringens in
the small intestine (Kim et al., 2011) and ceca (Yang et al., 2008) as well as reduced
disease mortality and severity (Mohamed and S Abdel Hafez, 2011). Nonetheless, a
previous study demonstrated that neither addition of FOS or MOS in feed significantly
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affected weight gain, feed conversion rate, and NE mortality in 6-week-old broilers (L.
Hofacre et al., 2003).
1.7.2.3

Organic acids
Organic acids are extensively used in feed due to their preservative effects on

fungal and microbial inhibitions, (Kum et al., 2010). In addition, they also exert the
antibacterial activity for a long time (Nieman, 1954). These acids used as additives in
feed enhance growth, feed utilization, and the conversion rate for broilers (Hassan et al.,
2010). Among them, lauric acid, a member of medium-chain fatty acids (MCFAs), was
found to have strong in vitro antimicrobial activity against gram-positive organisms
(Hermans et al., 2012; Van Immerseel et al., 2004a; Zeiger et al., 2017) and C.
perfringens (Skrivanova et al., 2005; Timbermont et al., 2010). Butyrate, a short-chain
fatty acid (SCFA), does not inhibit C. perfringens in birds (Jerzsele et al., 2012) but could
promote the growth of villus (Kien et al., 2007) and is beneficial for the prevention or
regeneration of epithelial damages (Timbermont et al., 2010). Organic acids have not
been shown to effectively protect chickens from NE as they protect against E. coli (Izat et
al., 1990) and Campylobacter (Chaveerach et al., 2004). A recent study demonstrated that
the combination of butyrate and lauric acid in feed gave the best protection against the
induction of NE lesions, indicating these additives can be used to control NE in broiler
chickens (Timbermont et al., 2010).
1.7.2.4

Plant extracts and essential oils
Essential oils are secondary compounds extracted from plants. They are

documented to improve intestinal health by enhancing digestions, modifying digestive
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secretions, and supporting the histology of the intestine (Diaz-Sanchez et al., 2015).
Besides, essential oils are particularly characterized as substances that engage in
antimicrobial activities. Carvacrol and thymol obtained from oregano as well as eugenol
from clove plants have been demonstrated to have an inhibitory effect against a wide
range of pathogenic bacteria (Dorman and Deans, 2000). For NE, thymol,
cinnamaldehyde, and eucalyptol were shown to have antimicrobial activity against C.
perfringens (Candan et al., 2003; Juneja and Friedman, 2007; Mitsch et al., 2004). Some
blends of essential oil even could reduce colonization and proliferation of C. perfringens
(Mitsch et al., 2004). In addition, essential oils have also been reported to have an
anticoccidial effect, thus may potentially have protective effects on NE (Giannenas et al.,
2003). However, the effectiveness of essential oils still varies (Cross et al., 2007;
Gonzalez-Gil et al., 2014) mainly because of the difference of their active components
from different methods of extraction, geographical origin, plant genotype, and storage
time (Clavijo and Florez, 2018). Further research is required to verify its effects on NE
prevention and control.
1.7.2.5

Feed enzymes
The objective of adding enzymes in the feed is to improve digestion that could

potentially reduce the risk of NE. Supplementation of xylanase into wheat-based diets has
been demonstrated to decrease digesta viscosity and fermentation, increase nutrient
digestion and digesta passage, and reduce the number of nutrients available to the
microflora (Choct et al., 1999; Guo et al., 2014). In addition, xylanase could alleviate the
impairment of intestinal mucosal barrier induced by C. perfringens challenge (Liu et al.,
2012). The inclusion of β-mannanase in the feed was shown to reduce the severity of NE
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in broiler chickens, but the effect was not superior to bacitracin or salinomycin treatment
to limit the severity of lesions (Jackson et al., 2003). The addition of exogenous lysozyme
significantly reduced the concentration of C. perfringens in the ileum and the intestinal
lesion scores, suggesting that the lysozyme could decrease C. perfringens colonization
and subsequently reduce the NE incidence (Liu et al., 2010). However, supplementation
of pentosanase in a wheat-based diet did not affect the level of NE-induced mortality
(Riddell and Kong, 1992). Furthermore, the addition of protease and xylanase in the diets
of broiler chickens did not reveal significant mitigation effect on NE-affected birds
(Barekatain et al., 2013). These contradictory results indicate the supplementation of
exogenous enzymes alone cannot provide sufficient protection. It should be incorporated
with other interventions to exert the synergistic effect against NE.
1.8

Summary
NE, not resembling other clostridial diseases, is a complex disease that involves

the participation of the pathogen, contributory factors, and host responses. Its economic
significance drives the poultry industry to seek for solutions to control the disease.
Nevertheless, the multifactorial nature of its pathogenesis makes the prevention and
control of NE a real challenge. Although advances in NE research have greatly
contributed to identifying predisposing factors and preventative resources, the ultimate
goal of effectively preventing and treating NE without the aid of AGPs has not been
achieved. To date, application of strategies such as the use of vaccines, prebiotics,
probiotics, or other feed additives demonstrated a variable degree of protection against
NE without consistent efficacy. Therefore, continuing works on the understanding of
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pathogenesis and interaction of contributory factors with C. perfringens are required for
developing practical measures to prevent and control this disease.

21

1.9

References

Abildgaard, L., Sondergaard, T.E., Engberg, R.M., Schramm, A., Hojberg, O., 2010. In
vitro production of necrotic enteritis toxin B, NetB, by netB-positive and netBnegative Clostridium perfringens originating from healthy and diseased broiler
chickens. Veterinary Microbiology 144, 231-235.
Alimolaei, M., Golchin, M., Abshenas, J., Ezatkhah, M., Bafti, M.S., 2018. A
Recombinant Probiotic, Lactobacillus casei, Expressing the Clostridium
perfringens alpha-toxoid, as an Orally Vaccine Candidate Against Gas Gangrene
and Necrotic Enteritis. Probiotics Antimicrob Proteins 10, 251-257.
Allaart, J.G., de Bruijn, N.D., van Asten, A.J., Fabri, T.H., Grone, A., 2012. NetBproducing and beta2-producing Clostridium perfringens associated with
subclinical necrotic enteritis in laying hens in the Netherlands. Avian Pathology
41, 541-546.
Annett, C.B., Viste, J.R., Chirino-Trejo, M., Classen, H.L., Middleton, D.M., Simko, E.,
2002. Necrotic enteritis: effect of barley, wheat and corn diets on proliferation of
Clostridium perfringens type A. Avian Pathology 31, 598-601.
Antonissen, G., Croubels, S., Pasmans, F., Ducatelle, R., Eeckhaut, V., Devreese, M.,
Verlinden, M., Haesebrouck, F., Eeckhout, M., De Saeger, S., Antlinger, B.,
Novak, B., Martel, A., Van Immerseel, F., 2015. Fumonisins affect the intestinal
microbial homeostasis in broiler chickens, predisposing to necrotic enteritis.
Veterinary Research 46, 98.
Antonissen, G., Van Immerseel, F., Pasmans, F., Ducatelle, R., Haesebrouck, F.,
Timbermont, L., Verlinden, M., Janssens, G.P., Eeckhaut, V., Eeckhout, M., De
Saeger, S., Hessenberger, S., Martel, A., Croubels, S., 2014. The mycotoxin
deoxynivalenol predisposes for the development of Clostridium perfringensinduced necrotic enteritis in broiler chickens. PloS One 9, e108775.
Awad, M.M., Bryant, A.E., Stevens, D.L., Rood, J.I., 1995. Virulence studies on
chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange
provide genetic evidence for the essential role of alpha-toxin in Clostridium
perfringens-mediated gas gangrene. Molecular Microbiology 15, 191-202.
Bailey, M.A., Macklin, K.S., Krehling, J.T., 2015. Low Prevalence of netB and tpeL in
Historical Clostridium perfringens Isolates from Broiler Farms in Alabama. Avian
Diseases 59, 46-51.
Barekatain, M.R., Antipatis, C., Rodgers, N., Walkden-Brown, S.W., Iji, P.A., Choct, M.,
2013. Evaluation of high dietary inclusion of distillers dried grains with solubles
22

and supplementation of protease and xylanase in the diets of broiler chickens
under necrotic enteritis challenge. Poultry Science 92, 1579-1594.
Batz, M.B., Hoffmann, S., Morris, J.G., Jr., 2012. Ranking the disease burden of 14
pathogens in food sources in the United States using attribution data from
outbreak investigations and expert elicitation. Journal of Food Protection 75,
1278-1291.
Beckmann, L., Simon, O., Vahjen, W., 2006. Isolation and identification of mixed linked
beta -glucan degrading bacteria in the intestine of broiler chickens and partial
characterization of respective 1,3-1,4-beta -glucanase activities. Journal of Basic
Microbiology 46, 175-185.
Brennan, J., Bagg, R., Barnum, D., Wilson, J., Dick, P., 2001a. Efficacy of narasin in the
prevention of necrotic enteritis in broiler chickens. Avian Diseases 45, 210-214.
Brennan, J., Moore, G., Poe, S.E., Zimmermann, A., Vessie, G., Barnum, D.A., Wilson,
J., 2001b. Efficacy of in-feed tylosin phosphate for the treatment of necrotic
enteritis in broiler chickens. Poultry Science 80, 1451-1454.
Caly, D.L., D'Inca, R., Auclair, E., Drider, D., 2015. Alternatives to Antibiotics to
Prevent Necrotic Enteritis in Broiler Chickens: A Microbiologist's Perspective.
Frontiers in Microbiology 6, 1336.
Candan, F., Unlu, M., Tepe, B., Daferera, D., Polissiou, M., Sokmen, A., Akpulat, H.A.,
2003. Antioxidant and antimicrobial activity of the essential oil and methanol
extracts of Achillea millefolium subsp. millefolium Afan. (Asteraceae). Journal of
Ethnopharmacology 87, 215-220.
Carman, R.J., 1997. Clostridium perfringens in spontaneous and antibiotic-associated
diarrhoea of man and other animals. Reviews in Medical Microbiology 8, S46.
Casewell, M., Friis, C., Marco, E., McMullin, P., Phillips, I., 2003. The European ban on
growth-promoting antibiotics and emerging consequences for human and animal
health. Journal of Antimicrobial Chemotherapy 52, 159-161.
Centers for Disease Control and Prevention, 2017. Prevent Illness from C. perfringens.
Retrieved from https://www.cdc.gov/features/clostridiumperfringens/index.html.
Chalmers, G., Bruce, H.L., Hunter, D.B., Parreira, V.R., Kulkarni, R.R., Jiang, Y.F.,
Prescott, J.F., Boerlin, P., 2008. Multilocus sequence typing analysis of
Clostridium perfringens isolates from necrotic enteritis outbreaks in broiler
chicken populations. Journal of Clinical Microbiology 46, 3957-3964.

23

Chambers, J., Gong, J., 2011. The intestinal microbiota and its modulation for Salmonella
control in chickens, Vol 44, 3149-3159 pp.
Chaveerach, P., Keuzenkamp, D.A., Lipman, L.J., Van Knapen, F., 2004. Effect of
organic acids in drinking water for young broilers on Campylobacter infection,
volatile fatty acid production, gut microflora and histological cell changes.
Poultry Science 83, 330-334.
Chen, J., McClane, B.A., 2015. Characterization of Clostridium perfringens TpeL toxin
gene carriage, production, cytotoxic contributions, and trypsin sensitivity.
Infection and Immunity 83, 2369-2381.
Choct, M., Annison, G., 2007. The inhibition of nutrient digestion by wheat pentosans.
British Journal of Nutrition 67, 123.
Choct, M., Hughes, R.J., Bedford, M.R., 1999. Effects of a xylanase on individual bird
variation, starch digestion throughout the intestine, and ileal and caecal volatile
fatty acid production in chickens fed wheat. British Poultry Science 40, 419-422.
Clavijo, V., Florez, M.J.V., 2018. The gastrointestinal microbiome and its association
with the control of pathogens in broiler chicken production: A review. Poultry
Science 97, 1006-1021.
Collado, M.C., Gueimonde, M., Hernandez, M., Sanz, Y., Salminen, S., 2005. Adhesion
of selected Bifidobacterium strains to human intestinal mucus and the role of
adhesion in enteropathogen exclusion. Journal of Food Protection 68, 2672-2678.
Collier, C.T., Hofacre, C.L., Payne, A.M., Anderson, D.B., Kaiser, P., Mackie, R.I.,
Gaskins, H.R., 2008. Coccidia-induced mucogenesis promotes the onset of
necrotic enteritis by supporting Clostridium perfringens growth. Veterinary
Immunology and Immunopathology 122, 104-115.
Cooper, K.K., Songer, J.G., 2009. Necrotic enteritis in chickens: a paradigm of enteric
infection by Clostridium perfringens type A. Anaerobe 15, 55-60.
Cooper, K.K., Songer, J.G., Uzal, F.A., 2013. Diagnosing clostridial enteric disease in
poultry. Journal of Veterinary Diagnostic Investigation 25, 314-327.
Cooper, K.K., Songer, J.G., Uzal, F.A., Songer, J.G., Prescott, J.F., Popoff, M.R. 2016.
Necrotic Enteritis of Poultry, In: Clostridial Diseases of Animals. John Wiley &
Sons, Inc, 123-137.
Coursodon, C.F., Glock, R.D., Moore, K.L., Cooper, K.K., Songer, J.G., 2012. TpeLproducing strains of Clostridium perfringens type A are highly virulent for broiler
chicks. Anaerobe 18, 117-121.
24

Craven, S.E., 2000. Colonization of the intestinal tract by Clostridium perfringens and
fecal shedding in diet-stressed and unstressed broiler chickens. Poultry Science
79, 843-849.
Crespo, R., Fisher, D.J., Shivaprasad, H.L., Fernandez-Miyakawa, M.E., Uzal, F.A.,
2007. Toxinotypes of Clostridium perfringens isolated from sick and healthy
avian species. Journal of Veterinary Diagnostic Investigation 19, 329-333.
Crhanova, M., Hradecka, H., Faldynova, M., Matulova, M., Havlickova, H., Sisak, F.,
Rychlik, I., 2011. Immune response of chicken gut to natural colonization by gut
microflora and to Salmonella enterica serovar enteritidis infection. Infection and
Immunity 79, 2755-2763.
Cross, D.E., McDevitt, R.M., Hillman, K., Acamovic, T., 2007. The effect of herbs and
their associated essential oils on performance, dietary digestibility and gut
microflora in chickens from 7 to 28 days of age. British Poultry Science 48, 496506.
Dahiya, J.P., Wilkie, D.C., Van Kessel, A.G., Drew, M.D., 2006. Potential strategies for
controlling necrotic enteritis in broiler chickens in post-antibiotic era. Animal
Feed Science and Technology 129, 60-88.
Daube, G., Simon, P., Limbourg, B., Manteca, C., Mainil, J., Kaeckenbeeck, A., 1996.
Hybridization of 2,659 Clostridium perfringens isolates with gene probes for
seven toxins (alpha, beta, epsilon, iota, theta, mu, and enterotoxin) and for
sialidase. American Journal of Veterinary Research 57, 496-501.
Diaz-Sanchez, S., D'Souza, D., Biswas, D., Hanning, I., 2015. Botanical alternatives to
antibiotics for use in organic poultry production. Poultry Science 94, 1419-1430.
Dorman, H.J., Deans, S.G., 2000. Antimicrobial agents from plants: antibacterial activity
of plant volatile oils. Journal of Applied Microbiology 88, 308-316.
Drew, M.D., Syed, N.A., Goldade, B.G., Laarveld, B., Van Kessel, A.G., 2004. Effects of
dietary protein source and level on intestinal populations of Clostridium
perfringens in broiler chickens. Poultry Science 83, 414-420.
Forder, R.E., Howarth, G.S., Tivey, D.R., Hughes, R.J., 2007. Bacterial modulation of
small intestinal goblet cells and mucin composition during early posthatch
development of poultry. Poultry Science 86, 2396-2403.
Freedman, J.C., Shrestha, A., McClane, B.A., 2016. Clostridium perfringens Enterotoxin:
Action, Genetics, and Translational Applications. Toxins 8.
25

Freedman, J.C., Theoret, J.R., Wisniewski, J.A., Uzal, F.A., Rood, J.I., McClane, B.A.,
2015. Clostridium perfringens type A-E toxin plasmids. Research in
Microbiology 166, 264-279.
Gabriel, I., Lessire, M., Mallet, S., Guillot, J.F., 2006. Microflora of the digestive tract:
critical factors and consequences for poultry. World's Poultry Science Journal 62,
499-511.
Gaucher, M.L., Quessy, S., Letellier, A., Arsenault, J., Boulianne, M., 2015. Impact of a
drug-free program on broiler chicken growth performances, gut health,
Clostridium perfringens and Campylobacter jejuni occurrences at the farm level.
Poultry Science 94, 1791-1801.
Gholamiandehkordi, A.R., Timbermont, L., Lanckriet, A., Van Den Broeck, W.,
Pedersen, K., Dewulf, J., Pasmans, F., Haesebrouck, F., Ducatelle, R., Van
Immerseel, F., 2007. Quantification of gut lesions in a subclinical necrotic
enteritis model. Avian Pathology 36, 375-382.
Gholamiandekhordi, A.R., Ducatelle, R., Heyndrickx, M., Haesebrouck, F., Van
Immerseel, F., 2006. Molecular and phenotypical characterization of Clostridium
perfringens isolates from poultry flocks with different disease status. Veterinary
Microbiology 113, 143-152.
Giannenas, I., Florou-Paneri, P., Papazahariadou, M., Christaki, E., Botsoglou, N.A.,
Spais, A.B., 2003. Effect of dietary supplementation with oregano essential oil on
performance of broilers after experimental infection with Eimeria tenella. Archiv
für Tierernahrung 57, 99-106.
Gibert, M., Jolivet-Reynaud, C., Popoff, M.R., 1997. Beta2 toxin, a novel toxin produced
by Clostridium perfringens. Gene 203, 65-73.
Gibson, G.R., Roberfroid, M.B., 1995. Dietary modulation of the human colonic
microbiota: introducing the concept of prebiotics. Journal of Nutrition 125, 14011412.
Gong, J., Forster, R.J., Yu, H., Chambers, J.R., Sabour, P.M., Wheatcroft, R., Chen, S.,
2002. Diversity and phylogenetic analysis of bacteria in the mucosa of chicken
ceca and comparison with bacteria in the cecal lumen. FEMS Microbiology
Letters 208, 1-7.
Gong, J., Si, W., Forster, R.J., Huang, R., Yu, H., Yin, Y., Yang, C., Han, Y., 2007. 16S
rRNA gene-based analysis of mucosa-associated bacterial community and
phylogeny in the chicken gastrointestinal tracts: from crops to ceca. FEMS
Microbiology Ecology 59, 147-157.
26

Gonzalez-Gil, F., Diaz-Sanchez, S., Pendleton, S., Andino, A., Zhang, N., Yard, C.,
Crilly, N., Harte, F., Hanning, I., 2014. Yerba mate enhances probiotic bacteria
growth in vitro but as a feed additive does not reduce Salmonella Enteritidis
colonization in vivo. Poultry Science 93, 434-440.
Grant, K.A., Kenyon, S., Nwafor, I., Plowman, J., Ohai, C., Halford-Maw, R., Peck,
M.W., McLauchlin, J., 2008. The identification and characterization of
Clostridium perfringens by real-time PCR, location of enterotoxin gene, and heat
resistance. Foodborne Pathogens and Disease 5, 629-639.
Grass, J.E., Gould, L.H., Mahon, B.E., 2013. Epidemiology of foodborne disease
outbreaks caused by Clostridium perfringens, United States, 1998-2010.
Foodborne Pathogens and Disease 10, 131-136.
Guo, S., Liu, D., Zhao, X., Li, C., Guo, Y., 2014. Xylanase supplementation of a wheatbased diet improved nutrient digestion and mRNA expression of intestinal
nutrient transporters in broiler chickens infected with Clostridium perfringens.
Poultry Science 93, 94-103.
Hamdy, A.H., Thomas, R.W., Kratzer, D.D., Davis, R.B., 1983. Lincomycin dose
response for treatment of necrotic enteritis in broilers. Poultry Science 62, 585588.
Hassan, H.M.A., Mohamed, M.A., Youssef, A.W., Hassan, E.R., 2010. Effect of Using
Organic Acids to Substitute Antibiotic Growth Promoters on Performance and
Intestinal Microflora of Broilers. Asian-Australas J Anim Sci 23, 1348-1353.
Hermans, D., Martel, A., Garmyn, A., Verlinden, M., Heyndrickx, M., Gantois, I.,
Haesebrouck, F., Pasmans, F., 2012. Application of medium-chain fatty acids in
drinking water increases Campylobacter jejuni colonization threshold in broiler
chicks. Poultry Science 91, 1733-1738.
Hermans, P.G., Morgan, K.L., 2007. Prevalence and associated risk factors of necrotic
enteritis on broiler farms in the United Kingdom; a cross-sectional survey. Avian
Pathology 36, 43-51.
Hoerr, F.J., 2010. Clinical aspects of immunosuppression in poultry. Avian Diseases 54,
2-15.
Hook, D., Jalaludin, B., Fitzsimmons, G., 1996. Clostridium perfringens food-borne
outbreak: an epidemiological investigation. Australian and New Zealand Journal
of Public Health 20, 119-122.
Izat, A.L., Tidwell, N.M., Thomas, R.A., Reiber, M.A., Adams, M.H., Colberg, M.,
Waldroup, P.W., 1990. Effects of a buffered propionic acid in diets on the
27

performance of broiler chickens and on microflora of the intestine and carcass.
Poultry Science 69, 818-826.
Jang, S.I., Lillehoj, H.S., Lee, S.H., Lee, K.W., Lillehoj, E.P., Hong, Y.H., An, D.J.,
Jeoung, D.H., Chun, J.E., 2013. Relative disease susceptibility and clostridial
toxin antibody responses in three commercial broiler lines coinfected with
Clostridium perfringens and Eimeria maxima using an experimental model of
necrotic enteritis. Avian Diseases 57, 684-687.
Jerzsele, A., Szeker, K., Csizinszky, R., Gere, E., Jakab, C., Mallo, J.J., Galfi, P., 2012.
Efficacy of protected sodium butyrate, a protected blend of essential oils, their
combination, and Bacillus amyloliquefaciens spore suspension against artificially
induced necrotic enteritis in broilers. Poultry Science 91, 837-843.
Jiang, Y., Mo, H., Willingham, C., Wang, S., Park, J.Y., Kong, W., Roland, K.L., Curtiss,
R., 3rd, 2015. Protection Against Necrotic Enteritis in Broiler Chickens by
Regulated Delayed Lysis Salmonella Vaccines. Avian Diseases 59, 475-485.
Juneja, V.K., Friedman, M., 2007. Carvacrol, cinnamaldehyde, oregano oil, and thymol
inhibit Clostridium perfringens spore germination and outgrowth in ground turkey
during chilling. Journal of Food Protection 70, 218-222.
Keto-Timonen, R., Heikinheimo, A., Eerola, E., Korkeala, H., 2006. Identification of
Clostridium species and DNA fingerprinting of Clostridium perfringens by
amplified fragment length polymorphism analysis. Journal of Clinical
Microbiology 44, 4057-4065.
Keyburn, A.L., Boyce, J.D., Vaz, P., Bannam, T.L., Ford, M.E., Parker, D., Di Rubbo,
A., Rood, J.I., Moore, R.J., 2008. NetB, a new toxin that is associated with avian
necrotic enteritis caused by Clostridium perfringens. PLoS Pathogens 4, e26.
Keyburn, A.L., Sheedy, S.A., Ford, M.E., Williamson, M.M., Awad, M.M., Rood, J.I.,
Moore, R.J., 2006. Alpha-toxin of Clostridium perfringens is not an essential
virulence factor in necrotic enteritis in chickens. Infection and Immunity 74,
6496-6500.
Keyburn, A.L., Yan, X.X., Bannam, T.L., Van Immerseel, F., Rood, J.I., Moore, R.J.,
2010. Association between avian necrotic enteritis and Clostridium perfringens
strains expressing NetB toxin. Veterinary Research 41, 21.
Kien, C.L., Blauwiekel, R., Bunn, J.Y., Jetton, T.L., Frankel, W.L., Holst, J.J., 2007.
Cecal infusion of butyrate increases intestinal cell proliferation in piglets. Journal
of Nutrition 137, 916-922.

28

Kim, D.K., Lillehoj, H.S., Jang, S.I., Lee, S.H., Hong, Y.H., Cheng, H.H., 2014.
Transcriptional profiles of host-pathogen responses to necrotic enteritis and
differential regulation of immune genes in two inbreed chicken lines showing
disparate disease susceptibility. PloS One 9, e114960.
Kim, G.B., Seo, Y.M., Kim, C.H., Paik, I.K., 2011. Effect of dietary prebiotic
supplementation on the performance, intestinal microflora, and immune response
of broilers. Poultry Science 90, 75-82.
Kleessen, B., Hartmann, L., Blaut, M., 2003. Fructans in the diet cause alterations of
intestinal mucosal architecture, released mucins and mucosa-associated
bifidobacteria in gnotobiotic rats. British Journal of Nutrition 89, 597-606.
Kum, S., Eren, U., Onol, A.G., Sandikci, M., 2010. Effects of dietary organic acid
supplementation on the intestinal mucosa in broilers, Vol 161, 463-468 pp.
L. Hofacre, C., Beacorn, T., Collett, S., Mathis, G., 2003. Using Competitive Exclusion,
Mannan-Oligosaccharide and Other Intestinal Products to Control Necrotic
Enteritis, Vol 12.
La Ragione, R.M., Woodward, M.J., 2003. Competitive exclusion by Bacillus subtilis
spores of Salmonella enterica serotype Enteritidis and Clostridium perfringens in
young chickens. Veterinary Microbiology 94, 245-256.
Langhout, D.J., Schutte, J.B., Van Leeuwen, P., Wiebenga, J., Tamminga, S., 1999.
Effect of dietary high- and low-methylated citrus pectin on the activity of the ileal
microflora and morphology of the small intestinal wall of broiler chicks. British
Poultry Science 40, 340-347.
Lee, K.W., Lillehoj, H.S., Jeong, W., Jeoung, H.Y., An, D.J., 2011. Avian necrotic
enteritis: experimental models, host immunity, pathogenesis, risk factors, and
vaccine development. Poultry Science 90, 1381-1390.
Lepp, D., Roxas, B., Parreira, V.R., Marri, P.R., Rosey, E.L., Gong, J., Songer, J.G.,
Vedantam, G., Prescott, J.F., 2010. Identification of novel pathogenicity loci in
Clostridium perfringens strains that cause avian necrotic enteritis. PloS One 5,
e10795.
Li, G.Q., Kanu, S., Xiang, F.Y., Xiao, S.M., Zhang, L., Chen, H.W., Ye, H.J., 2004.
Isolation and selection of ionophore-tolerant Eimeria precocious lines: E. tenella,
E. maxima and E. acervulina. Veterinary Parasitology 119, 261-276.
Li, J., Adams, V., Bannam, T.L., Miyamoto, K., Garcia, J.P., Uzal, F.A., Rood, J.I.,
McClane, B.A., 2013. Toxin plasmids of Clostridium perfringens. Microbiology
and Molecular Biology Reviews 77, 208-233.
29

Li, J., McClane, B.A., 2014. Contributions of NanI sialidase to Caco-2 cell adherence by
Clostridium perfringens type A and C strains causing human intestinal disease.
Infection and Immunity 82, 4620-4630.
Li, J., Sayeed, S., Robertson, S., Chen, J., McClane, B.A., 2011. Sialidases affect the host
cell adherence and epsilon toxin-induced cytotoxicity of Clostridium perfringens
type D strain CN3718. PLoS Pathogens 7, e1002429.
Lillehoj, H.S., Jang, S.I., Panebra, A., Lillehoj, E.P., Dupuis, L., Ben Arous, J., Lee, S.K.,
Oh, S.T., 2017. In ovo vaccination using Eimeria profilin and Clostridium
perfringens NetB proteins in Montanide IMS adjuvant increases protective
immunity against experimentally-induced necrotic enteritis. Asian-Australas J
Anim Sci 30, 1478-1485.
Liu, D., Guo, S., Guo, Y., 2012. Xylanase supplementation to a wheat-based diet
alleviated the intestinal mucosal barrier impairment of broiler chickens challenged
by Clostridium perfringens. Avian Pathology 41, 291-298.
Liu, D., Guo, Y., Wang, Z., Yuan, J., 2010. Exogenous lysozyme influences Clostridium
perfringens colonization and intestinal barrier function in broiler chickens. Avian
Pathology 39, 17-24.
Llanco, L.A., Nakano, V., Avila-Campos, M.J., 2015. Sialidase production and genetic
diversity in Clostridium perfringens type A isolated from chicken with necrotic
enteritis in Brazil. Current Microbiology 70, 330-337.
Marshall, B.M., Levy, S.B., 2011. Food animals and antimicrobials: impacts on human
health. Clinical Microbiology Reviews 24, 718-733.
Martin, T.G., Smyth, J.A., 2009. Prevalence of netB among some clinical isolates of
Clostridium perfringens from animals in the United States. Veterinary
Microbiology 136, 202-205.
McClane, B.A., 2007. Clostridium perfringens. In: Doyle, M.P. and Beuchat, L.R. (Eds.),
Food Microbiology: Fundamentals and Frontiers. Washington, DC: ASM Press;
p. 423-444.
McDevitt, R.M., Brooker, J.D., Acamovic, T., Sparks, N.H.C., 2007. Necrotic enteritis; a
continuing challenge for the poultry industry. World's Poultry Science Journal 62,
221-247.
Meimandipour, A., Shuhaimi, M., Hair-Bejo, M., Azhar, K., Kabeir, B.M., Rasti, B.,
Yazid, A.M., 2009. In vitro fermentation of broiler cecal content: the role of
30

lactobacilli and pH value on the composition of microbiota and end products
fermentation. Letters in Applied Microbiology 49, 415-420.
Mitsch, P., Zitterl-Eglseer, K., Kohler, B., Gabler, C., Losa, R., Zimpernik, I., 2004. The
effect of two different blends of essential oil components on the proliferation of
Clostridium perfringens in the intestines of broiler chickens. Poultry Science 83,
669-675.
Mohamed, M., S Abdel Hafez, M., 2011. The Effect of a Mannanoligosaccharides
(Biomos ) on ® Necrotic Enteritis Infection in Broiler Chickens, Vol 10.
Moore, R.J., 2016. Necrotic enteritis predisposing factors in broiler chickens. Avian
Pathology 45, 275-281.
Mot, D., Timbermont, L., Haesebrouck, F., Ducatelle, R., Van Immerseel, F., 2014.
Progress and problems in vaccination against necrotic enteritis in broiler chickens.
Avian Pathology 43, 290-300.
Murugesan, G.R., Ledoux, D.R., Naehrer, K., Berthiller, F., Applegate, T.J., Grenier, B.,
Phillips, T.D., Schatzmayr, G., 2015. Prevalence and effects of mycotoxins on
poultry health and performance, and recent development in mycotoxin
counteracting strategies. Poultry Science 94, 1298-1315.
Mwangi, W.N., Beal, R.K., Powers, C., Wu, X., Humphrey, T., Watson, M., Bailey, M.,
Friedman, A., Smith, A.L., 2010. Regional and global changes in TCRalphabeta T
cell repertoires in the gut are dependent upon the complexity of the enteric
microflora. Developmental & Comparative Immunology 34, 406-417.
Myers, G.S., Rasko, D.A., Cheung, J.K., Ravel, J., Seshadri, R., DeBoy, R.T., Ren, Q.,
Varga, J., Awad, M.M., Brinkac, L.M., Daugherty, S.C., Haft, D.H., Dodson, R.J.,
Madupu, R., Nelson, W.C., Rosovitz, M.J., Sullivan, S.A., Khouri, H., Dimitrov,
G.I., Watkins, K.L., Mulligan, S., Benton, J., Radune, D., Fisher, D.J., Atkins,
H.S., Hiscox, T., Jost, B.H., Billington, S.J., Songer, J.G., McClane, B.A., Titball,
R.W., Rood, J.I., Melville, S.B., Paulsen, I.T., 2006. Skewed genomic variability
in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome
Research 16, 1031-1040.
Nakano, V., Ignacio, A., Llanco, L., Bueris, V., Sircili, M.P., Avila-Campos, M.J., 2017.
Multilocus sequence typing analyses of Clostridium perfringens type A strains
harboring tpeL and netB genes. Anaerobe 44, 99-105.
Navarro, M.A., McClane, B.A., Uzal, F.A., 2018. Mechanisms of Action and Cell Death
Associated with Clostridium perfringens Toxins. Toxins 10.
Nieman, C., 1954. Influence of trace amounts of fatty acids on the growth of
microorganisms. Bacteriological Reviews 18, 147-163.
31

Novak, J.S., Juneja, V.K., McClane, B.A., 2003. An ultrastructural comparison of spores
from various strains of Clostridium perfringens and correlations with heat
resistance parameters. International Journal of Food Microbiology 86, 239-247.
Olkowski, A.A., Wojnarowicz, C., Chirino-Trejo, M., Laarveld, B., Sawicki, G., 2008.
Sub-clinical necrotic enteritis in broiler chickens: novel etiological consideration
based on ultra-structural and molecular changes in the intestinal tissue. Research
in Veterinary Science 85, 543-553.
Paiva, D., McElroy, A., 2014. Necrotic enteritis: Applications for the poultry industry.
The Journal of Applied Poultry Research 23, 557-566.
Pan, D., Yu, Z., 2014. Intestinal microbiome of poultry and its interaction with host and
diet. Gut Microbes 5, 108-119.
Park, S.S., Lillehoj, H.S., Allen, P.C., Park, D.W., FitzCoy, S., Bautista, D.A., Lillehoje,
E.P., 2008. Immunopathology and cytokine responses in broiler chickens
coinfected with Eimeria maxima and Clostridium perfringens with the use of an
animal model of necrotic enteritis. Avian Diseases 52, 14-22.
Patel, S., Goyal, A., 2012. The current trends and future perspectives of prebiotics
research: a review. 3 Biotech 2, 115-125.
Petit, L., Gibert, M., Popoff, M.R., 1999. Clostridium perfringens: toxinotype and
genotype. Trends in Microbiology 7, 104-110.
Prescott, J.F., Parreira, V.R., Mehdizadeh Gohari, I., Lepp, D., Gong, J., 2016a. The
pathogenesis of necrotic enteritis in chickens: what we know and what we need to
know: a review. Avian Pathology 45, 288-294.
Prescott, J.F., Smyth, J.A., Shojadoost, B., Vince, A., 2016b. Experimental reproduction
of necrotic enteritis in chickens: a review. Avian Pathology 45, 317-322.
Qu, A., Brulc, J.M., Wilson, M.K., Law, B.F., Theoret, J.R., Joens, L.A., Konkel, M.E.,
Angly, F., Dinsdale, E.A., Edwards, R.A., Nelson, K.E., White, B.A., 2008.
Comparative metagenomics reveals host specific metavirulomes and horizontal
gene transfer elements in the chicken cecum microbiome. PloS One 3, e2945.
Rehman, H.U., Vahjen, W., Awad, W.A., Zentek, J., 2007. Indigenous bacteria and
bacterial metabolic products in the gastrointestinal tract of broiler chickens.
Archives of Animal Nutrition 61, 319-335.
Riddell, C., Kong, X.M., 1992. The influence of diet on necrotic enteritis in broiler
chickens. Avian Diseases 36, 499-503.
32

Rood, J.I., 1998. Virulence genes of Clostridium perfringens. Annual Review of
Microbiology 52, 333-360.
Saengkerdsub, S., Anderson, R.C., Wilkinson, H.H., Kim, W.K., Nisbet, D.J., Ricke,
S.C., 2007a. Identification and quantification of methanogenic Archaea in adult
chicken ceca. Applied and Environmental Microbiology 73, 353-356.
Saengkerdsub, S., Herrera, P., Woodward, C.L., Anderson, R.C., Nisbet, D.J., Ricke,
S.C., 2007b. Detection of methane and quantification of methanogenic archaea in
faeces from young broiler chickens using real-time PCR. Letters in Applied
Microbiology 45, 629-634.
Sarker, M.R., Carman, R.J., McClane, B.A., 1999. Inactivation of the gene (cpe)
encoding Clostridium perfringens enterotoxin eliminates the ability of two cpepositive C. perfringens type A human gastrointestinal disease isolates to affect
rabbit ileal loops. Molecular Microbiology 33, 946-958.
Sayeed, S., Uzal, F.A., Fisher, D.J., Saputo, J., Vidal, J.E., Chen, Y., Gupta, P., Rood,
J.I., McClane, B.A., 2008. Beta toxin is essential for the intestinal virulence of
Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop
model. Molecular Microbiology 67, 15-30.
Scallan, E., Hoekstra, R.M., Angulo, F.J., Tauxe, R.V., Widdowson, M.A., Roy, S.L.,
Jones, J.L., Griffin, P.M., 2011. Foodborne illness acquired in the United States-major pathogens. Emerging Infectious Diseases 17, 7-15.
Schiemann, D.A., 1977. Laboratory confirmation of an outbreak of Clostridium
perfringens food poisoning. Health Laboratory Science 14, 35-38.
Schlundt J., 2015. Foodborne intoxications. In: Heymann, D.L. (Eds.), Control of
communicable diseases manual, Washington, DC: American Public Health
Association.
Sekirov, I., Finlay, B.B., 2009. The role of the intestinal microbiota in enteric infection.
Journal of Physiology 587, 4159-4167.
Servin, A.L., Coconnier, M.H., 2003. Adhesion of probiotic strains to the intestinal
mucosa and interaction with pathogens. Best Practice & Research: Clinical
Gastroenterology 17, 741-754.
Shawkat A. M'Sadeq, S.W., Robert A. Swick, Mingan Choct, 2015. Towards the control
of necrotic enteritis in broiler chickens with in-feed antibiotics phasing-out
worldwide. Animal Nutrition 1, 1-11.

33

Shimizu, T., Ohtani, K., Hirakawa, H., Ohshima, K., Yamashita, A., Shiba, T.,
Ogasawara, N., Hattori, M., Kuhara, S., Hayashi, H., 2002. Complete genome
sequence of Clostridium perfringens, an anaerobic flesh-eater. Proceedings of the
National Academy of Sciences of the United States of America 99, 996-1001.
Shojadoost, B., Vince, A.R., Prescott, J.F., 2012. The successful experimental induction
of necrotic enteritis in chickens by Clostridium perfringens: a critical review.
Veterinary Research 43, 74.
Siegel, P.B., Larsen, A.S., Larsen, C.T., Dunnington, E.A., 1993. Research note:
resistance of chickens to an outbreak of necrotic enteritis as influenced by major
histocompatibility genotype and background genome. Poultry Science 72, 11891191.
Skrivanova, E., Marounek, M., Dlouha, G., Kanka, J., 2005. Susceptibility of Clostridium
perfringens to C-C fatty acids. Letters in Applied Microbiology 41, 77-81.
Smyth, J.A., Martin, T.G., 2010. Disease producing capability of netB positive isolates of
C. perfringens recovered from normal chickens and a cow, and netB positive and
negative isolates from chickens with necrotic enteritis. Veterinary Microbiology
146, 76-84.
Songer, J.G., 1996. Clostridial enteric diseases of domestic animals. Clinical
Microbiology Reviews 9, 216-234.
Stanley, D., Hughes, R.J., Moore, R.J., 2014a. Microbiota of the chicken gastrointestinal
tract: influence on health, productivity and disease. Applied Microbiology and
Biotechnology 98, 4301-4310.
Stanley, D., Keyburn, A.L., Denman, S.E., Moore, R.J., 2012. Changes in the caecal
microflora of chickens following Clostridium perfringens challenge to induce
necrotic enteritis. Veterinary Microbiology 159, 155-162.
Stanley, D., Wu, S.B., Rodgers, N., Swick, R.A., Moore, R.J., 2014b. Differential
responses of cecal microbiota to fishmeal, Eimeria and Clostridium perfringens in
a necrotic enteritis challenge model in chickens. PloS One 9, e104739.
Stringfellow, K., McReynolds, J., Lee, J., Byrd, J., Nisbet, D., Farnell, M., 2009. Effect
of bismuth citrate, lactose, and organic acid on necrotic enteritis in broilers.
Poultry Science 88, 2280-2284.
Theoret, J.R., McClane, B.A., Uzal, F.A., Songer, J.G., Prescott, J.F., Popoff, M.R. 2016.
Toxins of Clostridium perfringens, In: Clostridial Diseases of Animals. John
Wiley & Sons, Inc, 45-60.
34

Thompson, D.R., Parreira, V.R., Kulkarni, R.R., Prescott, J.F., 2006. Live attenuated
vaccine-based control of necrotic enteritis of broiler chickens. Veterinary
Microbiology 113, 25-34.
Timbermont, L., De Smet, L., Van Nieuwerburgh, F., Parreira, V.R., Van Driessche, G.,
Haesebrouck, F., Ducatelle, R., Prescott, J., Deforce, D., Devreese, B., Van
Immerseel, F., 2014. Perfrin, a novel bacteriocin associated with netB positive
Clostridium perfringens strains from broilers with necrotic enteritis. Veterinary
Research 45, 40.
Timbermont, L., Haesebrouck, F., Ducatelle, R., Van Immerseel, F., 2011. Necrotic
enteritis in broilers: an updated review on the pathogenesis. Avian Pathology 40,
341-347.
Timbermont, L., Lanckriet, A., Dewulf, J., Nollet, N., Schwarzer, K., Haesebrouck, F.,
Ducatelle, R., Van Immerseel, F., 2010. Control of Clostridium perfringensinduced necrotic enteritis in broilers by target-released butyric acid, fatty acids
and essential oils. Avian Pathology 39, 117-121.
Timbermont, L., Lanckriet, A., Gholamiandehkordi, A.R., Pasmans, F., Martel, A.,
Haesebrouck, F., Ducatelle, R., Van Immerseel, F., 2009. Origin of Clostridium
perfringens isolates determines the ability to induce necrotic enteritis in broilers.
Comparative Immunology, Microbiology and Infectious Diseases 32, 503-512.
Titball, R.W., Naylor, C.E., Basak, A.K., 1999. The Clostridium perfringens alpha-toxin.
Anaerobe 5, 51-64.
Tsiouris, V., Georgopoulou, I., Batzios, C., Pappaioannou, N., Ducatelle, R., Fortomaris,
P., 2015a. The effect of cold stress on the pathogenesis of necrotic enteritis in
broiler chicks. Avian Pathology 44, 430-435.
Tsiouris, V., Georgopoulou, I., Batzios, C., Pappaioannou, N., Ducatelle, R., Fortomaris,
P., 2015b. High stocking density as a predisposing factor for necrotic enteritis in
broiler chicks. Avian Pathology 44, 59-66.
Uzal, F.A. 2016. Diseases Produced by Clostridium perfringens Type A in Mammalian
Species, In: Francisco A. Uzal , J.G.S., John F. Prescott, Michel R. Popoff (Ed.)
Clostridial Diseases of Animals. John Wiley & Sons, Inc.
Uzal, F.A., Freedman, J.C., Shrestha, A., Theoret, J.R., Garcia, J., Awad, M.M., Adams,
V., Moore, R.J., Rood, J.I., McClane, B.A., 2014. Towards an understanding of
the role of Clostridium perfringens toxins in human and animal disease. Future
Microbiology 9, 361-377.

35

Van Der Sluis, W., 2000. Clostridial enteritis is an often underestimated problem. World
poultry 16, 42-43.
Van Immerseel, F., De Buck, J., Boyen, F., Bohez, L., Pasmans, F., Volf, J., Sevcik, M.,
Rychlik, I., Haesebrouck, F., Ducatelle, R., 2004a. Medium-chain fatty acids
decrease colonization and invasion through hilA suppression shortly after
infection of chickens with Salmonella enterica serovar Enteritidis. Applied and
Environmental Microbiology 70, 3582-3587.
Van Immerseel, F., De Buck, J., Pasmans, F., Huyghebaert, G., Haesebrouck, F.,
Ducatelle, R., 2004b. Clostridium perfringens in poultry: an emerging threat for
animal and public health. Avian Pathology 33, 537-549.
Van Immerseel, F., Rood, J.I., Moore, R.J., Titball, R.W., 2009. Rethinking our
understanding of the pathogenesis of necrotic enteritis in chickens. Trends in
Microbiology 17, 32-36.
Wade, B., Keyburn., A., 2015. The true cost of necrotic enteritis. World Poultry 31, 16–
17.
Williams, R.B., 2002. Anticoccidial vaccines for broiler chickens: pathways to success.
Avian Pathology 31, 317-353.
Williams, R.B., 2005. Intercurrent coccidiosis and necrotic enteritis of chickens: rational,
integrated disease management by maintenance of gut integrity. Avian Pathology
34, 159-180.
Williams, R.B., Marshall, R.N., La Ragione, R.M., Catchpole, J., 2003. A new method
for the experimental production of necrotic enteritis and its use for studies on the
relationships between necrotic enteritis, coccidiosis and anticoccidial vaccination
of chickens. Parasitology Research 90, 19-26.
Yang, Y., Iji, P.A., Kocher, A., Mikkelsen, L.L., Choct, M., 2008. Effects of dietary
mannanoligosaccharide on growth performance, nutrient digestibility and gut
development of broilers given different cereal-based diets. Journal of Animal
Physiology and Animal Nutrition 92, 650-659.
Yeoman, C.J., Chia, N., Jeraldo, P., Sipos, M., Goldenfeld, N.D., White, B.A., 2012. The
microbiome of the chicken gastrointestinal tract. Animal Health Research
Reviews 13, 89-99.
Yin, Y., Lei, F., Zhu, L., Li, S., Wu, Z., Zhang, R., Gao, G.F., Zhu, B., Wang, X., 2010.
Exposure of different bacterial inocula to newborn chicken affects gut microbiota
development and ileum gene expression. ISME J 4, 367-376.
36

Zeiger, K., Popp, J., Becker, A., Hankel, J., Visscher, C., Klein, G., Meemken, D., 2017.
Lauric acid as feed additive - An approach to reducing Campylobacter spp. in
broiler meat. PloS One 12, e0175693.
Zhou, H., Lepp, D., Pei, Y., Liu, M., Yin, X., Ma, R., Prescott, J.F., Gong, J., 2017.
Influence of pCP1NetB ancillary genes on the virulence of Clostridium
perfringens poultry necrotic enteritis strain CP1. Gut Pathogens 9, 6.

37

CHAPTER II
CHARACTERIZATION OF TOXIN GENES AND QUANTITATIVE ANALYSIS OF
NETB IN NECROTIC ENTERITIS-PRODUCING AND NON-NE-PRODUCING
CLOSTRIDIUM PERFRINGENS ISOLATED FROM CHICKENS
(Accepted by Anaerobe)

Wen-Yuan Yanga, Chung-Hsi Choub, Chinling Wanga

a

Department of Basic Sciences, College of Veterinary Medicine, Mississippi State

University, Mississippi State, Mississippi, USA
b

Zoonoses Research Center and School of Veterinary Medicine, National Taiwan

University, Taipei City, Taiwan

38

Abstract
Necrotic enteritis (NE) in chickens, a Clostridium perfringens (C. perfringens)
infection, has re-emerged due to the removal of antibiotic growth promoters in feeds in
recent years, thus contributing to significant economic losses for the industry. Toxins
produced by C. perfringens in conjunction with predisposing factors are responsible for
the onset and development of NE. Recently, several lines of evidence indicated the
potential role of plasmid-encoded toxins in the virulence of NE, particularly necrotic
enteritis B-like (NetB) toxin. However, the association of NetB, beta2 toxin (CPB2), and
C. perfringens large cytotoxin (TpeL) in clinical NE isolates are not well-established.
Therefore, we characterized the toxinotype and the presence of netB, cpb2, and tpeL
genes in 15 NE-producing and 15 non-NE-producing C. perfringens isolates using
conventional PCR and quantified netB among those isolates by quantitative PCR (qPCR).
All isolates were characterized as toxinotype A and were negative for cpe, which is
associated with human food poisoning. The netB was detected in 6.7% and 70% of NEproducing isolates by PCR and qPCR, respectively. In 15 non-NE-producing isolates,
netB was not detected by conventional PCR, but was detected in 60% of isolates by
qPCR. The presence of and the copy number of netB were not significantly different
between NE- and non-NE-producing isolates (p > 0.05). No difference was observed
between NE- and non-NE-producing isolates in the presence of cpb2 or tpeL (p > 0.05).
These results suggest that the presence of netB, cpb2, and tpeL, as well as the copy
number of netB in C. perfringens is not correlated with clinical NE. In addition, we
suggest that qPCR, but not conventional PCR, be used to detect netB.
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2.1

Introduction
Necrotic enteritis (NE) is an important enteric disease in broiler chickens (Cooper

et al., 2013) characterized by necrosis and inflammation of the small intestine. NE is
caused by Clostridium perfringens, an anaerobic, endospore-forming, and a Grampositive bacterium, which results in significant levels of mortality in the clinical phase
and loss of productivity and poor feed conversion in the subclinical form. Up to 37.3% of
commercial broiler flocks could be affected by NE, contributing to an annual loss of 6.25
cents per bird and 6 billion dollars to the global poultry industry (Van Der Sluis, 2000;
Wade and Keyburn., 2015). In the past, in-feed antimicrobial growth promoters (AGPs)
were the most effective strategy used to control C. perfringens-associated NE in poultry
(Liu et al., 2010). However, the phase-out of AGPs due to concerns regarding the spread
of antibiotic resistance has resulted in a spike in NE incidence, and hence considered as a
re-emerging disease by the poultry industry (Casewell et al., 2003; Gaucher et al., 2015;
Timbermont et al., 2011; Van Immerseel et al., 2009).
C. perfringens is classified into A, B, C, D, and E toxinotypes based on the
production of four major toxins, alpha (α), beta (β), epsilon (ε), and iota (ι) toxins (Van
Immerseel et al., 2004). NetB, a pore-forming toxin from NE strains of C. perfringens,
has limited protein sequence identity to the beta-toxin of C. perfringens, which causes
mucosal necrosis of the small intestine in humans and animals. It plays a major role in the
virulence of NE based on an in vivo study demonstrating that the wild-type and
complemented netB C. perfringens strain produced characteristic lesions in the small
intestine, but a null mutant could not in contrast, a cpa mutant strain that did not produce
CPA toxin, still produced NE in an experimental challenge study (Keyburn et al., 2006).
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Although the expression of netB fulfilled the molecular Koch’s postulate, several lines of
evidence dispute the importance of netB on the pathogenesis. A proportion of C.
perfringens strains isolated from healthy chickens possess netB with some degree of in
vitro NetB toxin production, but these chickens do not develop NE after challenges with
netB-positive isolates (Abildgaard et al., 2010; Chalmers et al., 2008; Martin and Smyth,
2009). Low carriage rates of netB in C. perfringens isolates from NE-affected chicken
farms have been noted (Bailey et al., 2015), and isolates without netB also produce NE
(Abildgaard et al., 2010; Bailey et al., 2015; Llanco et al., 2015; Martin and Smyth, 2009;
Smyth and Martin, 2010). In addition, use of netB positive C. perfringens alone, without
predisposing factors, failed to consistently reproduce NE in the challenge model (Zhou et
al., 2017). These findings indicate that the pathogenesis of NE is highly complex and
other factors should be involved and crucial in the disease development. Meanwhile, a
number of studies demonstrated that predisposing factors were required for NE
development (Moore, 2016; Shojadoost et al., 2012; Williams, 2005), and with a
combination of predisposing factors, degradative enzymes, and toxins, C. perfringens
could conceivably trigger NE, resulting in intestinal tissue destruction, bacterial
colonization, and enterotoxicity (Bailey et al., 2015; Keyburn et al., 2008; Li et al., 2011).
Besides, isolations of netB-positive C. perfringens from healthy birds further provide the
evidence that a simple C. perfringens infection without other components is not sufficient
to induce NE. Therefore, it is worth examining the possibility that netB may originally
exist in all C. perfringens, not exclusively in NE-producing isolates.
Last but not least, Nakano et al. recently found that netB and tpeL were also
present in C. perfringens strains isolated from healthy humans by PCR assay (Nakano et
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al., 2017), pointing out the possibility that the presence of those genes may not correlate
with the virulence of NE. Based upon these findings, we hypothesized that C. perfringens
isolates from NE and non-NE chickens may harbor netB and other virulence genes
regardless of the origin of the isolates. Traditionally, analysis of toxin genes in C.
perfringens depends on a conventional or multiplex PCR, but quantitative real-time PCR
(qPCR) is recognized as the superior technique with higher sensitivity and quantitative
ability. Therefore, the aim of this study was to investigate the relevant toxin genes (cpa,
cpb, etx, iap, cpe, cpb2, tpeL, and netB) in NE-producing and non-NE-producing C.
perfringens by PCR and to quantify the virulence gene, netB, by qPCR. This study
provides a better understanding of the association of netB with clinical NE and also
demonstrates a sensitive qPCR assay to detect the presence of toxin gene.
2.2
2.2.1

Materials and methods
Isolation and identification of C. perfringens from NE-diseased and nonNE chickens
The jejunum was targeted and collected to isolate C. perfringens in this study.

NE-diseased chicken was defined by observing clinical symptoms and characteristic
lesions in the small intestine. On the contrary, non-NE chicken was grossly inspected and
determined by the absence of NE lesions in the same site of the gut. Fifteen jejunal tissue
samples of NE-diseased chickens were obtained from thirteen broiler farms. For non-NE
counterpart, four out of fifteen samples were collected from a processing plant and five
jejunums originated from chickens at each different houses within two separated farms.
The remaining samples were collected from specific pathogen free (SPF) layers and
broilers evenly in untreated control groups of two chicken trails. Afterwards, C.
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perfringens were isolated by streaking scrapings of the jejunal mucus membrane on blood
agar plates (Fisher Scientific, Pittsburgh, Pennsylvania, USA) followed by an overnight
anaerobic incubation at 37°C. The anaerobic condition was achieved by using container
system sachets (BD Biosciences, San Jose, California, USA) or anaerobic jar (Sigma, St.
Louis, Missouri, USA) with anaerobic gas generators (Fisher Scientific). A single colony
with double hemolytic zones was subsequently transferred to an egg yolk agar plate
(HiMedia, Mumbai, Maharashtra, India) for an additional overnight anaerobic incubation
at 37°C. Following incubation, a colony harboring a positive lecithinase reaction was
selected and cultured on a highly selective tryptone sulfite neomycin (TSN) agar plate
(Sigma) and incubated anaerobically at 46°C for an additional 18 to 20 hours. A black
colony presumptively identified as C. perfringens was then transferred to 10 ml
thioglycolate broth (Himedia) and anaerobically incubated at 37°C overnight for further
identification, total DNA extraction, and stock storage. Each strain or isolate was
confirmed as C. perfringens using RapID ANA II biochemical tests (Fisher Scientific)
and PCR assays targeting the 16S rRNA gene (Table 2.1).
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Table 2.2

PCR and qPCR targeted genes for C. perfringens, according primers and
amplicon lengths

GenBank
Gene accession

Primers

Sequence (5′-3′)

number

Tm

Product

(℃)

(bp)

Reference

cpa

L43545

CPA5L
CPA5R

AGTCTACGCTTGGGATGGAA
TTTCCTGGGTTGTCCATTTC

55

900

(Fan et al.,
2016)

cpb

X83275

CPBL
CPBR

TCCTTTCTTGAGGGAGGATAAA
TGAACCTCCTATTTTGTATCCCA

56

611

(Fan et al.,
2016)

cpb2

L77965

CPB2L
CPB2R

AGATTTTAAATATGATCCTAACC
CAATACCCTTCACCAAATACTC

53

567

(Garmory et
al., 2000)

etx

M95206

CPETXL TGGGAACTTCGATACAAGCA
CPETXR TTAACTCATCTCCCATAACTGCAC

56

396

(Fan et al.,
2016)

iap

X73562

CPIL
CPIR

AAACGCATTAAAGCTCACACC
CTGCATAACCTGGAATGGCT

57

293

(Fan et al.,
2016)

cpe

X81849

CPEL
CPER

GGGGAACCCTCAGTAGTTTCA
ACCAGCTGGATTTGAGTTTAATG

57

506

(Fan et al.,
2016)

tpeL EU848493

TPELF
TPELR

ATATAGAGGCAAGCAGTGGAG
GGAATACCACTTGATATACCTG

55

466

(Coursodon
et al., 2012)

netB GU433338

NETBL
NETBR

TGATACCGCTTCACATAAAGGTTGG
ATAAGTTTCAGGCCATTTCATTTTTCCG

61

169

This study

16S
rRNA

16SL
16SR

CATCATTCAACCAAAGGAGCAATCC
CATTATCTTCCCCAAAGACAGAGC

60

262

This study

2.2.2

Y12669

Bacterial DNA extraction
Total DNA was isolated from the overnight broth-brown culture inoculated with

single colony of C. perfringens from plate by using an Ultraclean Microbial DNA
Isolation Kit (Mobio, Germantown, Maryland, USA) following the manufacturer’s
instructions with some modifications. Briefly, the bacterial suspension was mixed with a
lysis buffer and 20 μl of 20 mg/ml proteinase K (Fisher Scientific). The mixture was
subsequently incubated at 65℃ for 15 minutes to lyse the bacterial cell wall and to
prevent DNase digestion of DNA. In order to avoid DNA shearing, the tube containing
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the reaction mixture was secured on a flat pad and horizontally vortexed for 10 minutes.
DNA was sequentially eluted with 30 μl 10 mM Tris-HCl (pH 8.0), separated on a 0.8%
agarose gel (BD Biosciences) for the quality assurance, and stored at -20℃ until use.
2.2.3

PCR amplification of C. perfringens toxin genes
Major toxin genes, including cpa, cpb, etx, and iap, as well as minor toxin genes,

cpe, netB, cpb2, and tpeL, were detected by PCR with specific primers (Table 2.1).
ATCC strains 13124, 3626, 12917, 51880, and 27324 were used as reference strains for
toxinotyping (A, B, C, D, and E, respectively) and as positive controls for cpb2 and cpe.
Strain JP17 kindly provided by Dr. John F. Prescott was used as the positive control for
netB and tpeL. PCR amplification was performed in a 20-μl volume containing 50 ng
template DNA, 10× Taq buffer (NH4)2SO4, 1.5 mM MgCl2, 0.2 mM dNTP mix, 1U Taq
DNA polymerase (Fisher Scientific, Pittsburgh, Pennsylvania, USA), and 0.2 μM of each
primer on a thermocycler (Applied Biosystems GeneAmp PCR System 9700). The
protocol was as follows: 1 cycle of 95℃ for 2 minutes; 35 cycles of 95℃ for 1 minute,
annealing temperature for 1 minute, and 72℃ for 1 minute; and a final extension at 72℃
for 10 minutes. For netB, the assay conditions were modified to: 1 cycle of 95℃ for 3
minutes; 35 cycles of 95℃ for 30 seconds, annealing temperature for 30 seconds, and
72℃ for 30 seconds; a final extension cycle of 72℃ for 5 minutes. The amplified
products were analyzed on a 1.5% agarose gel and stained with SYBR Safe DNA Gel
Stain (Fisher Scientific). PCR amplified products on the gels were extracted, purified,
and sequenced to ensure 100% match of reference sequences.
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2.2.4

Quantitative real-time PCR (qPCR)
To estimate relative abundance of netB in NE- and non-NE-producing C.

perfringens isolates, 20 μl reaction mixture was analyzed using a QuantStudio 5 RealTime PCR System (Fisher Scientific). The mixture contained 10 μl PowerUp SYBR
Green Master Mix (Fisher Scientific), 0.5 μM netB primer (Table 2.1), and 100 ng
template DNA. Three technical replicates along with corresponding positive and negative
controls were included for each plate. The qPCR amplification cycles were as follows: 1
cycle of 95°C for 2 minutes; followed by 45 cycles of denaturation at 95°C for 5 seconds,
annealing and extension at 60°C for 30 seconds, and dissociation steps at 95°C for 1
second; 60°C for 20 seconds; and 95°C for 1 second. To differentiate the specific netB
amplicon from non-specific products, the DNA melting curve was performed to confirm
the specific amplicon. Likewise, amplified products were separated on 1.5% agarose gels
to confirm that the size was the same as the positive control.
2.2.5

Efficiency of the qPCR assay
The PCR product of netB was cloned into pGEM® -T Easy Vector Systems

(Promega, Madison, Wisconsin, USA) to generate plasmid DNA containing specific
sequence of netB. The amplification efficiency (AE) of the qPCR for netB was examined
using a 10-fold serial dilution of the plasmid DNA ranged from 1 ng to 100 attogram
(ag). Standard curve was established based on the threshold cycles (Ct) plotted against
the log10 values of the gene copies (Log-copy). The linearity was observed with the
equation: y = -3.4571x + 38.397 (R2 = 0.9999; AE = 95%), where y is the threshold
cycles and x is the amount of the targeted gene with log10 value (Figure 2.1).
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Figure 2.1

Standard curve of netB by qPCR.

It shows Ct-values of isolate samples plotted versus the log value of quantified netB copy
numbers. The 10-fold serial dilutions (from 1 ng to 100 ag) were prepared ranging from
2.92 × 108 to 29.2 copies of netB gene. The linearity was observed with the equation: y =
-3.4571x + 38.397 (R2 = 0.9999; AE = 95%).
2.2.6

Statistical analysis
The average threshold cycle (Ct) from the positive replicate samples was used for

calculating the copy number of netB, which was expressed as log10 copies/100 ng DNA.
After log transformation of the copy number, the difference in copies between NE- and
non-NE-producing C. perfringens was analyzed with the Wilcoxon Rank-Sum Test using
SAS software version 9.4 (SAS Institute, Inc., Cary, North Carolina, USA). Fisher’s
exact test was used to compare the difference in frequency of netB, cpb2, and tpeL
between NE- and non-NE-producing C. perfringens isolates. A level of 0.05 was
considered statistically significant.
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2.3

Results

2.3.1

Isolate identification
Thirty C. perfringens isolates were recovered from the jejunum of clinical NE and

non-NE chickens in 15 broiler farms, one processing plant, and two experimental control
groups (Table 2.2). All isolates were identified as C. perfringens through biochemical
tests and 16S rRNA gene sequence confirmation by PCR.
Table 2.3

Distribution of toxin genes and copy number of netB in NE- and non-NEproducing Clostridium perfringens isolates
netB

Isolate

Origin

Source

Health
status

Type

cpa

cpb

etx

iap

cpe

cpb2

tpeL

JP17

Reference

N/A

N/A

A

+

–

–

–

–

+

1N
2N
3N
4N
5N
6N
7N
8N
9N
10N
11N
12N
13N
14N
15N
1C
2C
3C
4C
5C
6C
7C
8C
9C
10C
11C
12C
13C
14C
15C

Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Broiler
Layer
Layer
Layer
Broiler
Broiler
Broiler

F1
F2
F3
F4
F5
F6
F7
F8
F9
F10
F11
F12

NE
NE
NE
NE
NE
NE
NE
NE
NE
NE
NE
NE
NE
NE
NE

A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

+
–
+
+
–
–
+
+
+
+
+
+
+
–
+
+
+
+
+
+
+
+
+
+
–
–
–
–
–
–

F13; H2
F13; H2
F13; H2

P1
P1
P1
P1

non-NE

F14; H1

non-NE

F14; H2

non-NE

F14; H3

non-NE

F15; H1

non-NE

F15; H2

non-NE

EC1
EC1
EC1
EC2
EC2
EC2

non-NE

non-NE
non-NE
non-NE

non-NE
non-NE
non-NE
non-NE
non-NE
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Copies/100 ng

PCR

qPCR

+

+

+

>2.92×108

+
–
–
–
–
–
+
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

+
–
–
–
–
–
+
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

+
–
+
+
+
+
+
+
+
+
+
+
–
–
–
+
+
–
–
–
+
+
+
+
–
+
+
–
+
–

>2.92×108

DNA

–
7.26× 103
4.19× 10
<2.92× 10
1.35× 103
>2.92×108
<2.92× 10
1.76×103
<2.92×10
<2.92×10
<2.92×10
–
–
–
3.11×10
7.49×10
–
–
–
2.96×10
4.40×10
<2.92×10
<2.92×10
–
7.23× 10
<2.92× 10
–
6.45×10
–

Abbreviations: F, farm; H: house; P, processing plant; EC, experimental control; NE,
necrotic enteritis; non-NE, chickens not affected by NE or healthy.
The copies of netB was calculated by the equation: y = -3.4571x + 38.397 (R2 = 0.9999;
AE = 95%).
No significant difference of mean log-copies of netB between NE and non-NE group
(Wilcoxon Rank-Sum Test; p > 0.05).
2.3.2

Toxinotyping and detection of toxin genes by PCR
All thirty C. perfringens isolates were characterized as toxinotype A (Table 2.2).

None of these isolates carried cpb, etx, iap, or cpe. Of the thirty isolates, twenty (66.7%)
harbored cpb2 (11 in the NE group and 9 in the non-NE group), two possessed netB
(6.7%), and two had tpeL (6.7%). The prevalence of cpb2, netB and tpeL in NEproducing isolates was higher than that in the non-NE producing isolates. However, no
statistical significance was noted. The simultaneous carriage of netB and tpeL was
observed in two isolates.
2.3.3

qPCR
The carriage rate of netB in NE-producing C. perfringens was 73% (11/15)

compared with 60% (9/15) in the non-NE-producing isolates (Table 2.3). The NEproducing C. perfringens carried a higher copy number of netB than the non-NEproducing isolates; however, there was no statistically significant difference (p > 0.05).
Copies of netB in NE-producing isolates varied among different farms. Six NE-producing
isolates carried lower netB copy number than non-NE producing isolates.
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Table 2.4

Comparative results of netB carriage by PCR and qPCR in NE- and nonNE-producing Clostridium perfringens isolates
Status

NE
non-NE
2
0
Conventional
13
15
netB –
PCR
Subtotal
15
15
netB +
11
9
qPCR
4
6
netB –
Subtotal
15
15
Abbreviations: NE, necrotic enteritis; non-NE, chickens not affected by NE or healthy.
No significant difference of prevalence detected by qPCR between NE and non-NE group
(Fisher’s exact test; p > 0.05).
netB +

2.3.4

Comparison of the netB detection by conventional PCR and qPCR
The detection rate of netB in total C. perfringens isolates was 6.7% (2/30) by PCR

compared to 66.7% (20/30) by qPCR. In detail, the netB gene was recognized in 13.3%
(2/15) and 73.3% (11/15) of NE-producing isolates by PCR and qPCR, respectively.
However, netB was not found in non-NE producing isolates by PCR, whereas 60% of
these isolates (9/15) were positive for netB by qPCR (Table 2.3).
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2.4

Discussion
C. perfringens isolates recovered from NE-producing chickens in this study were

all toxinotype A, but were negative for cpe, which is consistent with previous studies
(Keyburn et al., 2006; Van Immerseel et al., 2009). The pathogenesis of NE has been the
subject of considerable interest for over a decade in order to develop effective prevention
and mitigation strategies. The NetB toxin, encoded by netB, was shown to be an
important virulence factor through several experimental challenge studies and
epidemiological surveys (Johansson et al., 2010; Keyburn et al., 2010a; Martin and
Smyth, 2009). However, a recent study found that netB alone, in the absence of other
NELoc-1 genes, was unable to restore full virulence in the challenge model performed by
Zhou et al. (Zhou et al., 2017). This finding suggested that other genes present in the
same pathogenicity locus, NELoc-1, and their encoded products were required for
regulation of netB and for full virulence. Furthermore, global gene expression of netB
harbored by C. perfringens was demonstrated to be highly modulated by environmental
conditions (Parreira et al., 2016). These results indicate that netB may exist in each C.
perfringens isolate, and the disease development depends on certain regulatory
mechanisms to either activate or suppress genes. In other words, C. perfringens isolated
from NE and non-NE chickens may all possess netB, but it may only be expressed under
certain conditions, promoting the development of NE. Thus, the carriage and quantity of
netB in NE- and non-NE-producing C. perfringens isolates were re-assessed in this study.
The low detection rate of netB by PCR (6.7%) was consistent with that of a previous
study (4.1%) (Bailey et al., 2015), indicating that NetB was not an important virulence
factor, or at least not as important as originally thought. Nevertheless, qPCR data
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demonstrated that the prevalence of netB was high in both NE and non-NE isolates (73%
versus 60%, respectively), showing that netB is present in the majority of C. perfringens
regardless of NE production status. No significant difference of prevalence was observed
between these two groups regardless of the detection method was used. The netB gene
could be detected at the amount of 10-20 copies by qPCR, whereas high copy numbers
(~108) were required for a positive identification by PCR in this study. Abildgaard et al.
(Abildgaard et al., 2010) noted the potential significance of NetB toxin in virulence;
however, the presence or absence of netB in C. perfringens itself is insufﬁcient to predict
the pathogenicity. Regarding the quantity of netB, NE-producing C. perfringens isolates
possessed higher copy numbers than non-NE isolates on average. Among eleven NEproducing C. perfringens isolates, two had abundant copies of netB, while the remaining
nine carried relatively low copies of netB and yet still established clinical NE, suggesting
that the quantity of netB in C. perfringens is not a reliable indicator of pathogenicity as
well.
NE-producing C. perfringens strains/isolates typically carry two to five highly
conserved, low-copy number plasmids (Lepp et al., 2010). The netB, cpb2, and tpeL toxin
genes are encoded in pathogenicity loci on different large plasmids (Bannam et al., 2011;
Lepp et al., 2013; Lepp et al., 2010). As C. perfringens ordinarily relies on plasmidencoded toxins to produce NE in chickens (Li et al., 2013), the prevalence of cpb2 and
tpeL, in addition to netB, were selected for this investigation. Several epidemiological
studies suggest that cpb2-positive C. perfringens isolates are highly associated with
enteric diseases in domestic animals (Waters et al., 2005). In the present study, the high
carriage rate of cpb2 in NE and non-NE isolates was observed by PCR; this result was
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consistent with other findings (Crespo et al., 2007; Gholamiandekhordi et al., 2006; Park
et al., 2015; Siragusa et al., 2006). We also found that cpb2 was not differently
distributed between isolates from NE-producing and healthy chickens, which disputes
that there is an association between cpb2 and NE, as previously reported by Crespo et al.
(Crespo et al., 2007).
Regarding tpeL, our PCR data were in accordance with other findings (Bailey et
al., 2015; Chalmers et al., 2008; Keyburn et al., 2010b) and revealed low frequencies of
tpeL carriage in NE-producing isolates. The tpeL gene was found only in netB-positive
isolates. These observations indicate that the putative TpeL toxin may not be essential for
NE in chickens due to such a low carriage rate. However, one study demonstrated that
several tpeL-positive C. perfringens in the absence of netB causes typical NE in the
disease induction model (Llanco et al., 2015), proposing that the TpeL toxin or another
toxin plays a role in NE pathogenesis. In another challenge experiment, inoculation of
broilers with tpeL- and netB-positive strains was associated with greater severity of gross
lesions compared with strains containing only netB, suggesting that tpeL potentiates the
effect of other virulence attributes of NE strains (Coursodon et al., 2012). Collectively,
these data indicate that the role of tpeL in pathogenesis remains inconclusive.
In summary, we demonstrated that a qPCR assay was a sensitive and reliable
method for characterization and quantification of netB in C. perfringens. The results
provide not only new insights into the prevalence of potential virulence toxin genes in C.
perfringens populations from NE and non-NE chickens, but also a conclusion that the
presence or absence of those genes as well as the quantity of netB are insufﬁcient to
predict an association with the virulence or pathogenicity. As NE is a multifactorial
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disease, the understandings of gut microbiota, environmental conditions, and regulation
of virulence genes and attributes are recommended and those are rationally required to
elucidate the dynamic pathogenesis of C. perfringens.
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Abstract
The netB-positive Clostridium perfringens (C. perfringens) has been considered
as the requisite to consistently induce necrotic enteritis (NE). However, use of a netBpositive strain did not guarantee consistent NE reproduction unless high protein diets or
Eimeria, conceived as two major predisposing factors, was incorporated. To establish a
refined model, the roles of dietary fishmeal inclusion, Eimeria inoculation, and netBpositive C. perfringens challenge in NE induction and the confounding effects of Eimeria
infection on NE were examined. The results showed that the use of netB-positive C.
perfringens without a predisposing factor failed to induce NE. Fishmeal incorporation
promoted the occurrence of NE but did not significantly affect the incidence of the
disease in conjunction with the challenge of netB-positive C. perfringens. However, the
additional participation of Eimeria infection in the same induction procedure produced
significantly higher numbers of NE cases and promoted more severe lesions in chickens
(p < 0.05). Inoculation of Eimeria resulted in a significantly higher incidence of NE
compared to the non-Eimeria treated group (p < 0.05). The results demonstrated that both
netB-positive C. perfringens and predisposing factors were required for the reproduction
of the disease. Mild to moderate coccidial infection (coccidial lesion score ≤ 2) was noted
in NE cases in this model but severe coccidial infection did not correlate with the
occurrence of NE, indicating mild coccidial infection may be beneficial for the
development of NE. If multiple species infection of Eimeria precedes the challenge of C.
perfringens, days 19 to 21 (1 to 3 days after the last clostridial challenge) was the time
period favorable for observations of NE lesions. The time after this period may be subject
to the bias of severity, incidence, or mortality of NE owing to the profound coccidial
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lesions in the intestinal region. This study demonstrated that the co-infection with netBpositive C. perfringens and Eimeria species under fishmeal incorporation produced a
desirable NE model, being of value in studying the effectiveness of novel feed additives
and alternative mitigation strategies to prevent NE.
3.1

Introduction
Necrotic enteritis (NE), an enteric disease caused by Clostridium perfringens (C.

perfringens) type A, contributes enormous economic losses to the poultry industry
worldwide and is currently being considered as a major global threat (Timbermont et al.,
2009; Van Der Sluis, 2000; Van Immerseel et al., 2009; Wade and Keyburn., 2015). In
past decades, the use of in-feed antibiotics or antimicrobial growth promoters (AGPs)
was the most effective approach to prevent and control this disease (Liu et al., 2010).
However, due to the rising concerns about the spread of bacteria with antibiotic resistance
from animals to humans, numerous countries and companies have consequently
prohibited the use of AGPs. The withdrawal of AGPs has resulted in a spike in the
incidence of NE and has led to the reemergence of this disease in the broiler production
system (Casewell et al., 2003; Gaucher et al., 2015; Timbermont et al., 2011; Van
Immerseel et al., 2009). The resurgence and dissemination of NE have promoted urgent
demands for alternatives to mitigate this economically significant disease.
The occurrence of clostridial enteritis is primarily correlated with the proliferation of
Clostridia in the intestinal tract, which is followed by the incremental production of
toxins (Theoret et al., 2016). Toxins are recognized as the critical components that induce
the lesions and clinical signs of clostridial enteritis (Awad et al., 1995; Keyburn et al.,
2008; Sarker et al., 1999; Sayeed et al., 2008; Uzal et al., 2014). In chickens, the netB
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gene, encoding necrotic enteritis B-like (NetB) toxin, has been recently shown to play a
leading role in the virulence of NE (Keyburn et al., 2008), and several experimental
studies demonstrated that a reliable NE induction model mainly relied on the strain of C.
perfringens that is netB-positive (Cooper and Songer, 2010; Keyburn et al., 2010; Smyth
and Martin, 2010; Timbermont et al., 2009). However, the isolation of netB-positive C.
perfringens from healthy chickens (Martin and Smyth, 2009) indicates that an infection
of this type of bacteria without other components is not sufficient to induce NE. Given
the ubiquity of C. perfringens, the disease often fails to develop without other
predisposing factors (Craven, 2000; Van Immerseel et al., 2004). Therefore, a great
number of studies have demonstrated that disease induction of NE is highly complex,
normally requiring more than just bacterial infection both experimentally and in the field.
The process of disease induction is dynamic and involves many steps, including
colonization, multiplication, acquisition of nutrients, evasion of the host defenses,
infliction of damage, and transmission (Prescott et al., 2016a). This multifactorial feature
of this disease contributes to difficulties in achieving consistent results in the
experimental reproduction of NE.
Feed manipulation is the most widely applied predisposing factor implemented prior
to NE induction. This involves making changes in feed ingredients in the period before C.
perfringens challenge (Uzal et al., 2015). Chickens fed with wheat-based diets are shown
more susceptible to NE than those fed with corn-based diets (Branton et al., 1987; Riddell
and Kong, 1992). Similarly, a high level of fishmeal in the diet has been demonstrated to
predispose chickens to or exacerbate the outbreak of NE (Drew et al., 2004;
Gholamiandehkordi et al., 2007; Johnson and Pinedo, 1971; Truscott and Al-Sheikhly,
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1977). High levels of non-starch polysaccharides (NSP) in wheat exert its effects by
increasing the viscosity of the digesta and hence slowing transit time in the gut (Annett et
al., 2002). NSP can also leave undigested nutrients available for microbial proliferation
and interact with glycoproteins on the epithelial surface to increase mucin production
(Kleessen et al., 2003), thus promoting the overgrowth of C. perfringens (Shojadoost et
al., 2012). High animal protein diets, especially those based on fishmeal, provide high
levels of available nutrients, such as specific amino acids that C. perfringens is unable to
synthesize, subsequently improving bacterial growth (Drew et al., 2004; Titball et al.,
1999). Moreover, a biogenic amine known as gizzerozine is present in fishmeal and can
lead to erosions in the alimentary tract of birds (Tisljar et al., 2002). Lastly, the addition
of fishmeal in the diet can destabilize and alter the underlying gut microbial population,
thus predisposing chickens to develop NE (Stanley et al., 2012; Stanley et al., 2014b).
Switching to a high fishmeal or protein diet during a C. perfringens challenge has been
linked to successful NE induction (Keyburn et al., 2008; Wu et al., 2010).
Coccidial infection is another predisposing factor that has been extensively used to
develop NE. Eimeria in the gut has multiple effects that promote the development of NE
in chickens. First, Eimeria infection leads to physical damage to the gut epithelium and
thus facilitates the colonization and proliferation of C. perfringens (Van Immerseel et al.,
2009; Williams, 2005; Williams et al., 2003). At the same time, the damage contributes
to ruptured epithelial cells leaking plasma proteins to the gut lumen, which acts as a rich
nutrient source for C. perfringens growth (Van Immerseel et al., 2004). Moreover,
coccidial infection also induces a host mucogenic response to produce mucus, providing
another protein-rich nutrient source for the growth advantage of C. perfringens (Collier et
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al., 2008; Forder et al., 2012). Lastly, an Eimeria infection may exert an immunological
stress on chickens, increasing their susceptibility to C. perfringens infection (Uzal et al.,
2015).
Although quite a number of predisposing factors have been unveiled and
incorporated with the process of clostridial infection, the reproducibility of the clinical
NE model is still variable under experimental conditions (Van Waeyenberghe et al.,
2016). The success and severity of reproduced NE have been demonstrated to depend on
the strain of C. perfringens, diet, the species of Eimeria, and the route, dose, timing, and
frequency of the challenge (Prescott et al., 2016b). To establish a refined NE model that
can assess the efficacy of novel feed additives and the contribution of the gut microbial
profile to NE, the effects of two most widely used predisposing factors on disease
induction by C. perfringens harboring the recognized virulent toxin gene were
investigated. The influence of Eimeria species parasitizing different gut locations on the
success of NE induction was also evaluated. The need for a consistent NE induction
model prompted us to study the interaction between net-positive C. perfringens, wheatfishmeal mixed diet, and multiple species of Eimeria; the resulting data provides practical
operational guidelines for the experimental reproduction of NE.
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3.2

Materials and Methods

3.2.1

Chickens and diets
A total of 147 male and female one-day-old unvaccinated broiler chicks (Cobb

strain) from commercial hatcheries were used. Sixty-three chicks were assigned to trial 1
and 84 chicks were allotted to trial 2. Chicks were randomly grouped and placed in
separate iron tanks with nets in the floor-pen facility and lined with fresh litter. Feed and
water were provided ad libitum. No antibiotics and anticoccidials were added in feeds.
For trial 1, Natural Chick Starter/Grower commercial feed (Co-op, Starkville,
Mississippi) containing minimal 18% crude protein was applied throughout the entire
experiment. In trial 2, a wheat-based diet was prepared based on the formula previously
described by Branton (Branton et al., 1987). The diet was further mixed with fishmeal
60N (Seven Springs Farm, Check, Virginia) having minimal 60% crude protein at a ratio
of 1:1 to form wheat-based diets containing 50% fishmeal (fishmeal diet). The wheatbased diets were fed to chickens for the first 7 days, and then the rations were replaced by
fishmeal diets from day 8 to day 19. Afterward, wheat-based diets were resupplied until
the end of the trial.
3.2.2

Experimental designs

A side-by-side experimental design was implemented with the different combination
of netB-positive C. perfringens (CP1) and predisposing factors. The reproduction of NE
was evaluated based on clinical signs and intestinal lesion scored 2 or more. In trial 1, no
predisposing factor was applied for NE induction. Sixty-three broiler chicks were
randomly divided into three groups and fed with non-medicated starter/grower feeds. A
tenfold dose of a commercial coccidial vaccine was orally administered to the Eimeria65

treated group at 9 days of age to establish the coccidial infection. For the induction of
NE, 3 ml of freshly prepared CP1 inoculum at 2.5x108 colony-forming units (CFU)/ml
was gavaged per os once per day starting on day 14 for 3 consecutive days by using an 18
G curved, round-tipped animal feeding needle with 2 mm tip diameter
(Gavageneedle.com, Sherman Oaks, California). Subsequently, 7 chickens from each
group were humanely euthanized by carbon dioxide and scored for NE or coccidial
lesions at day 17, 19, and 23.
In trial 2, dietary and parasitic predisposing factors were included to evaluate their
effects on the induction of NE with CP1. Eighty-four chicks were equally assigned to 4
groups in a completely randomized design that included a CP1-challenged group, a coinfection group with CP1 and Eimeria species, an Eimeria-treated group, and a control
group. Eimeria was provided for Eimeria-treated groups using the same methodology
described in trial 1 at day 10. The infection of C. perfringens was achieved by orally
administrating 3 ml of CP1 inoculum starting at day 15 for 4 consecutive days at a
frequency of 3 times a day. Chickens in each group were euthanized at day 19 and day
21. The information concerning experimental designs is listed in Table 3.1.
Chickens in both trials were clinically inspected on a daily basis. Whole small
intestine (duodenum, jejunum, and ileum) and cecum were targeted for pathological
examination of NE and coccidial lesions. One specialized veterinarian was in charge of
necropsy and lesion scoring. Dead chickens were removed from trials after identifying
the cause of death by necropsy and recording the corresponding information, such as pen,
date, and lesion score. These trials were reviewed and approved by the Mississippi State
University Institutional Animal Care and Use Committee (IACUC-16-439).
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Table 3.1
Trial N1
1

21

Trial designs

Group

Dietary
factor2

Clostridial
challenge

Coccidial
challenge

CP1

-

d14, d15,d16

-

Sampling time
d17 (P1D)3, d19
(P3D)4, d23 (P7D)

5

21
Eimeria
d9
d17, d19, d23
5
21
CTL
d17, d19, d23
2
21
CP1
+
d15, d16, d17, d18
d19 (P1D), d21 (P3D)
21
Eimeria5
+
d10
d19, d21
21 CP1+Eimeria5
+
d15, d16, d17, d18
d10
d19 (P1D), d21 (P3D)
21
CTL5
+
d19, d21
1
Number of chickens.
2
Dietary factor: the wheat-based diet containing 50% fishmeal (Fishmeal diet).
3
P1D: 1 day after the last challenge of CP1.
4
P3D: 3 days after the last challenge of CP1.
5
Eimeria: multi-species Eimeria; CTL: control group.

3.2.3

Strains and preparation of inocula

In this study, multiple species of Eimeria were applied to predispose chickens to
NE. The design was based on the evidence that natural infections by Eimeria are
generally due to a mixture of more than one species (Williams, 2003). A coccidial live
vaccine, containing live oocysts of 4 Eimeria species, including E. acervulina, E.
maxima, E. maxima MFP, E. mivati, and E. tenella, was selected to induce coccidiosis in
chickens. One vaccine bottle contained 10,000 doses of oocysts in an unspecified
proportion of Eimeria species. A tenfold dose of vaccine was prepared as the inoculum
by dilution using autoclaved distilled and deionized water and then applied on Eimeriatreated and co-infection groups.
The netB-positive C. perfringens used in the trials was strain CP1, kindly
provided by Dr. John F. Prescott (Ontario Agricultural College, University of Guelph,
Canada). It is a clinical NE isolate identified as toxinotype A and tpeL-negative by PCR.
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This strain has been demonstrated to favorably reproduce NE in a number of
experimental models (Jiang et al., 2009; Thompson et al., 2006; Yu et al., 2017; Zhou et
al., 2017). To prepare the inoculum, CP1 was streaked on blood agar plates (Fisher
Scientific, Pittsburgh, Pennsylvania) followed by an overnight anaerobic incubation at
37°C. A single colony with double hemolytic zones was subsequently transferred to 3 ml
fluid thioglycollate (FTG) medium (Himedia, Mumbai, Maharashtra, India) and
anaerobically incubated at 37°C overnight. Thereafter, the bacterial suspension was
transferred into fresh FTG broth at a ratio of 1:10, and the mixture was incubated at 37°C
for specific time points (15 hours for trial 1; 15, 19, and 23 hours for trial 2) to acquire
the fresh inocula applied in the two trials. The bacterial concentration of each inoculum
(CFU/ml) was determined by plating 100 μl of the inoculum culture on Brain Heart
Infusion agar (Sigma-Aldrich, St. Louis, Missouri) plates, followed by anaerobic
incubation at 37°C for 16 hours and counting the numbers of colonies. The whole broth
culture was used to induce NE based on previous evidence that clostridia with toxins in
the supernatant produce more severe disease than cells only (Thompson et al., 2006).
3.2.4

Macroscopic lesion scoring
The lesion score in each intestinal tissue was a single-blinded evaluation. The

scores of gross intestinal NE lesions (duodenum to ileum) were recorded in accordance
with the criteria of Keyburn (Keyburn et al., 2006) and ranged from 0 (no gross lesions),
1 (congested intestinal mucosa), 2 (small focal necrosis or ulceration; one to five foci), 3
(focal necrosis or ulceration; 6 to 15 foci), and 4 (focal necrosis or ulceration; 16 or more
foci). Chickens with lesion scores of 2 or more were identified as NE positive. After
comparing scores of duodenum, jejunum, and ileum, the highest score was determined as
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the final NE lesion score for each chicken. For coccidial infections, the small intestine
and cecum were both examined and scored following the system described by Johnson
and Reid (Johnson and Reid, 1970). This scoring system, ranging from one to four (0 for
a normal appearance of the intestine), was used to assess the infection of E. acervulina,
E. maxima, and E. tenella.
3.2.5

Statistical analysis
SAS software version 9.4 (SAS Institute, Inc., Cary, North Carolina, USA) was

used for statistical analysis. Significant differences in NE lesion scores between groups
were determined by Tukey test. Fisher's exact test was conducted to evaluate the
differences of NE incidence levels between treatment and non-treatment groups with
respect to fishmeal and Eimeria species. Statements of statistical significance were based
on the level of p < 0.05.
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3.3
3.3.1

Results
Induction of NE by netB-positive C. perfringens with and without
predisposing factors
We examined the ability of CP1 to produce NE with and without dietary and

parasitic predisposing factors in our model. In trial 1, which did not include any dietary
predisposing factor of NE, chickens challenged with CP1 exhibited simple hyperemic or
congested mucosa in the small intestines at each time sampling point (Figure 3.1A; Table
3.2). A higher number of chickens having a lesion score of 1 was noted in the CP1challenged group compared to the control, but no NE cases (lesion score ≥ 2) were
identified.

Figure 3.1

Macroscopic NE lesions produced by CP1 in challenged chickens.

(A) Hyperemia or congestion on jejunal mucus membrane (Score 1); (B) Multifocal
necrosis on duodenal mucosa (score 3); (C) Multifocal necrosis on jejunal mucosa (score
3); (D) Confluent necrosis on the mucosa of the jejunum covered by pseudo-membranes
(Score 4).
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Table 3.2

The frequency of NE lesions by groups

NE lesion score
Dietary
Subtotal NE case
1
factor
0
1
2
3
4
1
CP1
1
20
0
0
0
21
0
CTL2
12
9
0
0
0
21
0
2
CP1
+
0
17
1
1
0
19
2
CP1+Eimeria2
+
0
14
0
4
1
19
5
2
CTL
+
6
15
0
0
0
21
0
1
Dietary factor: the wheat-based diet containing 50% fishmeal (Fishmeal diet).
2
Eimeria: multi-species Eimeria; CTL: control group.
Trial

Group

In contrast, thickened intestinal walls, which were not observed in trial 1, were
noticed in a higher portion of chickens in the control group that ingested fishmeal diets in
the second trial (Table 3.2), showing that a fishmeal diet promoted apparent mucosal
damage in the small intestine. Characteristic macroscopic lesions of NE were found in the
CP1-challenged group as well as the CP1-Eimeria co-infected group. The affected
chickens displayed variable degrees of clinical signs, including depression, reluctance to
move, diarrhea and ruffled feathers. A total of two and five NE cases were reproduced in
the CP1-challenged and co-infection groups, respectively. These cases demonstrated
focal or multifocal to coalescing necrosis of the intestinal mucosa (Figure 3.1B, Figure
3.1C, and Figure 3.1D). Four out of five (80%) NE-affected chickens in the co-infection
group displayed lesions in both duodenum and jejunum. The most severe lesions were
found in the jejunum, between its proximal end and Meckel’s diverticulum. No NEcaused mortalities were recorded in the present study. The statistical analysis shows that
the CP1-challenged and co-infection groups both had significantly higher lesion scores
than the control group (Tukey test; p < 0.05), but the co-infection group exhibited the
highest difference (Tukey test; p < 0.01). Additionally, the co-infection group showed a
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significantly higher incidence of NE compared to the CP1-challenged group (p < 0.05).
These findings demonstrate that the co-infection of netB-positive C. perfringens and
Eimeria species and feeding with fishmeal in this model successfully reproduced NE.
Challenge with CP1 without the presence of predisposing factors was not sufficient to
produce clinical symptoms and a case of NE. Through the addition of fishmeal, two NE
cases with mild lesions were produced, and a significant difference in the incidence of
NE between groups fed with and without fishmeal was noted. However, in conjunction
with coccidial infection, five NE cases with severe lesions were specifically observed in
the CP1-challenged group (Table 3.2). The dot density of each NE case and the mean
lesion score with case number by groups are shown in Figure 3.2 and Table 3.3.

Figure 3.2

Dot density of NE case by groups in two experimental trials.

The data presents the mean NE lesion score ± SD with the frequency of NE. NE case was
defined by lesion score reaching 2 or above. Dissimilar letters indicate a significant
difference at a level of α=0.05 (Tukey’s test); * mean highly significant (p < 0.01).
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Table 3.3
Trial

Group

Severity and incidence of NE by groups in trials.
Dietary
factor1

Lesion score
(NE case2/chickens in group)
Day 19
Day 21
Day 23

Day 17
0.86
±0.353
(0/7)
0.29 ±
0.45
(0/7)

Average
0.95 ±
0.21
(0/21)
0.43 ±
0.49
(0/21)
1.16 ±
0.50a5
(2/19)
1.58 ±
1.0a*
(5/19)
0.71 ±
0.46b
(0/21)

1.00 ± 0
1.00 ± 0
(0/7)
(0/7)
0.43 ±
0.57 ±
CTL4
0.49
0.49
(0/7)
(0/7)
1.11 ±
1.20 ±
2
CP1
+
0.33
0.63
(1/9)
(1/10)
1.50 ±
1.67 ±
CP1+Eimeria
+
1.08
1.00
(2/10)
(3/9)
0.44 ±
0.92 ±
CTL
+
0.52;
0.29
(0/9)
(0/12)
1
Dietary factor: the wheat-based diet containing 50% fishmeal (Fishmeal diet).
2
NE case is defined by lesion score reaching 2 or above.
3
Lesion score is shown in mean ± SD.
4
CTL: control group.
5
Dissimilar letters indicate a significant difference at a level of α=0.05 (Tukey’s test); *
mean highly significant (p < 0.01).
1

3.3.2

CP1

-

Influence of the course of coccidial infection on NE induction and lesion
observations
The lesion score system was also applied to assess the severity of coccidial

development. It was evident that each species of Eimeria produced observable gross
changes in the intestine in either singly Eimeria-challenged or co-infected with CP1
groups. The pathological gross lesions are shown in Figure 3.3 and the distribution of
coccidial lesion scores by groups is summarized in Table 3.4. We observed that E.
acervulina occupied a much greater area from duodenum to proximal jejunum. The
severity of its infection spiked at day 19 and minimized at day 23 in trial 1. However, in
trail 2 that incorporated fishmeal as a dietary factor, severe lesions (score ≥ 3) resulted
from E. acervulina lesions observed at day 21. E. maxima commenced developing severe
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lesion at day 21 as well. None of the macroscopic lesions of E. maxima was noted in the
ileum in the two trials, indicating that this species caused slight or mild infestation to the
ileum of chickens in this timeframe or under a tenfold dose of the coccidial vaccine. For
the infection of E. tenella, bloody diarrhea was first observed at day 21. Severe diarrhea
and lesions (score 3 to 4) in the cecum were recorded on day 23, leading to mortality for
the afflicted chickens. At that time, mucosal discoloration to paleness was apparent, and
either CP1- or other Eimeria species-caused lesions affecting small intestines had
vanished.
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Figure 3.3

Coccidial infections by different species in trials.

(A) Characteristic lesions caused by E. acervulina in the duodenum. Numerous white
plaques on the mucous membrane and mucosal discoloration were observed (Score 3);
(B) Infection of E. maxima in the jejunum. Thickened intestinal wall with
watery contents and light orange mucus (Score 2). (C) & (D) Gross intestinal lesions
produced by E. tenella in the cecum. (C) Petechiae on the mucosal surfaces. The
thickened cecal wall which contained fibrin and blood (Score 2); (D) Distended ceca
filled with blood clots (Score 4).
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Table 3.4
Trial Site

Distribution of coccidial lesion score by groups with sampling times
Group

Lesion score2
Species

0

1

2

3

4

Total

Du1
Eimeria-D19 E. acervulina
0
0
0
0
7
Du
E.
acervulina
Eimeria-D23
0
6
0
0
0
2
Du
Eimeria-D19 E. acervulina
3
6
1
0
0
Du
Eimeria-D21 E. acervulina
0
2
8
1
0
Du
CP1+Eimeria-D19 E. acervulina
1
4
5
0
0
Du
CP1+Eimeria-D21 E. acervulina
0
0
7
2
0
1
1
Je
Eimeria-D19 E. acervulina
0
0
0
2
5
Je
Eimeria-D23 E. acervulina
0
4
2
0
0
2
Je
E. maxima
Eimeria-D19
7
3
0
0
0
Je
E. maxima
Eimeria-D21
0
3
4
4
0
Je
E. maxima
CP1+Eimeria-D19
7
3
0
0
0
Je
E. maxima
CP1+Eimeria-D21
0
4
4
1
0
1
1
Il
E. maxima
Eimeria-D19
0
7
0
0
0
Il
E. maxima
Eimeria-D23
0
6
0
0
0
2
Il
E. maxima
Eimeria-D19
10
0
0
0
0
Il
E.
maxima
Eimeria-D21
11
0
0
0
0
Il
E. maxima
CP1+Eimeria-D19
10
0
0
0
0
Il
E. maxima
CP1+Eimeria-D21
9
0
0
0
0
1
1
Ce
E. tenella
Eimeria-D19
7
0
0
0
0
Ce
E. tenella
Eimeria-D23
0
0
0
3
3
2
Ce
E. tenella
Eimeria-D19
0
9
1
0
0
Ce
E. tenella
Eimeria-D21
1
5
5
0
0
Ce
E. tenella
CP1+Eimeria-D19
0 10
0
0
0
Ce
E. tenella
CP1+Eimeria-D21
0
9
0
0
0
1
Du: duodenum; Je: jejunum; Il: ileum; Ce: cecum.
2
Lesion scores in duodenum, jejunum, ileum, and cecum were recorded according to
predominant lesions caused by the according Eimeria species.
1
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7
6
10
11
10
9
7
6
10
11
10
9
7
6
10
11
10
9
7
6
10
11
10
9

The pathological progress of coccidiosis differed between inoculated species, and
it affected the observation of lesions caused by NE. In the co-infection group, coccidial
lesions resulting from E. acervulina or E. maxima together with NE lesions were noticed.
On day 19 and 21, NE lesion could still be recognized. Mild to moderate coccidial
infection (coccidial lesion score ≤ 2) was noted in NE cases, but severe coccidial
infection did not correlate with the occurrence of NE. In the case of E. tenella, once the
coccidial infection became predominant, for instance on day 23, the gross lesions in the
intestine faded out except in the cecum. Therefore, day 19 to day 21 (or 1 to 3 days after
the last clostridial challenge) was the suggested timeframe to observe for NE lesions in
this model. After this period, assessing the severity, incidence, or mortality of NE became
biased owing to the profound coccidial lesions in the intestinal region; this was especially
evident if highly pathogenic species of Eimeria, such as E. tenella, were applied as a
predisposing factor of NE.
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3.4

Discussion
The influence of strains of C. perfringens is recognized as the key to establish a

reliable NE induction model (Uzal et al., 2015). In particular, the strain producing the
NetB toxin has been considered as the definitive cause of NE in chickens (Keyburn et al.,
2008). Many studies have demonstrated that only a netB-positive strain can reproducibly
induce consistent levels of NE (Cooper and Songer, 2010; Keyburn et al., 2010; Smyth
and Martin, 2010; Timbermont et al., 2009). In studies that applied predisposing factors
with netB-positive C. perfringens to induce the disease, the success of NE reproduction
has seldom been attributed to the provision of high-protein diets (Cooper and Songer,
2010; Keyburn et al., 2010; Timbermont et al., 2009) and/or Eimeria species (Smyth and
Martin, 2010; Timbermont et al., 2009). To the best of our knowledge, few studies have
addressed the association of predisposing factors with netB-positive C. perfringens on NE
reproduction. In the present study, we have demonstrated that the reproduction of NE in
vivo by the use of a netB-positive strain alone did not induce NE. Only if a dietary factor
or the combination of dietary and coccidial factors was used in conjunction with a netBpositive strain of C. perfringens did develop NE, and its severity and incidence increased.
These findings reveal that both netB-positive C. perfringens and predisposing factors are
required for the reproduction of the disease. This is in line with a recent study showing
that predisposing factors play a determinant role in NE induction (Li et al., 2017). The
authors surveyed the toxinotypes of C. perfringens from normal chickens, field NE cases,
and a human gas gangrene strain (ATCC 13124) and then examined their virulence in
vivo by using them to reproduce NE. The results showed that netB-positive C.
perfringens could not produce NE, whereas the same group co-infected with E. maxima
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did. Furthermore, they found that netB-negative C. perfringens from normal chickens and
field NE cases, even netB-negative strain 13124 could reproduce NE in conjunction with
E. maxima (Li et al., 2017). These findings provide further evidence that predisposing
factors have the weightier influence on the induction of NE than netB in C. perfringens.
The observation that the simple infection of C. perfringens is not sufficient to
produce disease led to the hypothesis that C. perfringens challenge on its own is not
capable of causing any significant perturbations in the intestinal microbiota that are
favorable for NE development (Stanley et al., 2014a). In this study, chickens in the CP1
challenge group of trial 1 without a dietary factor displayed some degree of mucosal
damage in the small intestine; however, the existence of mild mucosal damage without
contributing effects from other factors was not enough to create a gut environment
favorable for NE development. This agrees with the finding that the proliferation of C.
perfringens requires predisposing factors to either provide nutrients or create a favorable
niche both in disease outbreaks in the field and in models for experimental induction of
the disease (Shojadoost et al., 2012; Williams, 2005). On the other hand, co-infection
with Eimeria demonstrated the highest potential to facilitate NE development and
promote the severity of the disease in this study. Notably, fishmeal had less effect on NE
induction in the presence of netB-positive C. perfringens compared to Eimeria. These
results agree with a previous study in which Eimeria, preceding netB-positive C.
perfringens, greatly increased the severity of NE induced in broiler chickens, but
fishmeal addition played only a marginal role in the challenge model (Rodgers et al.,
2015). Moreover, a metagenomic analysis of gut microbiota showed that fishmeal and
Eimeria both generated significant changes in the microbial communities in the cecum,
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but Eimeria had the stronger influence on intestinal microbiota, thus potentially
promoting the induction of NE (Stanley et al., 2014b; Wu et al., 2010).
Although Eimeria species produce distinct lesions from those by NE, most vaccine
studies have adopted the NE induction model with dietary factors instead of Eimeria to
evaluate the effectiveness of a vaccine. This is due to the consideration that profound
coccidial lesions would complicate gross NE scoring and immunological effects elicited
by Eimeria might compromise the response of chickens to vaccination (Uzal et al., 2015).
Nevertheless, coccidiosis is frequently found to precede or occur concurrently with field
outbreaks of NE (Broussard et al., 1986; Gazdzinski and Julian, 1992; Long, 1973;
Porter, 1998). Both diseases tend to act synergistically since NE development strongly
depends on the intestinal damage resulting from coccidiosis (Van Immerseel et al., 2009;
Williams, 2005; Williams et al., 2003). The co-infection NE model with Eimeria actually
fits the field condition and could be reproduced in both the clinical form with mortality
and the subclinical form of NE (Gholamiandehkordi et al., 2007; Wu et al., 2010). In
addition, a number of Eimeria species had little influence on the induction of NE
challenge model (Van Waeyenberghe et al., 2016). Therefore, it would be of value and
significance using this model to study the efficacy of novel feed additives, management
strategies, and other mitigations toward NE.
E. acervulina, E. maxima, and E. tenella are the three species that most regularly
affect commercially reared chickens (Clark et al., 2016; Gyorke et al., 2013; McDougald,
1998). Depending on the magnitude of infection, Eimeria can cause mild to severe
lesions and significant pathology. During the life cycle, E. acervulina and E. maxima
both can contribute physical damage to the jejunal mucosa (Chapman, 2014), where C.
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perfringens initially colonizes and expands in numbers (Moore, 2016; Prescott et al.,
2016b). Thus, these two species have been most widely applied in NE induction. Owing
to concerns that profound coccidial lesions would complicate gross scoring of NE (Uzal
et al., 2015), the influence of the course of coccidial infection on NE induction and lesion
observations were evaluated. In the co-infection group, NE lesions occurred together with
coccidial lesions from mild to moderate infection (coccidial lesion score ≤ 2) of E.
acervulina and E. maxima. Although there were overlapping areas of lesions either in the
duodenum, jejunum, or both, NE lesions could still be well-recognized. However, severe
Eimeria-affected chickens (coccidial lesion score ≥ 3) did not produce NE, suggesting
that heavy coccidial infection might conceal the gross lesions of NE or alter
environmental conditions which compromise the NE development. The most severe
lesions of E. acervulina were recorded at day 19, and the severity declined to a mild
degree at day 23 in trial 1. However, severe lesions started to appear at day 21 in trial 2,
indicating that fishmeal might have some degree of delay effect on the development of
coccidial lesions for E. acervulina. Similar results were also observed in another trial
using the same methodology as trial 2 to induce NE and coccidiosis (data not shown). In
the case of the highly pathogenic E. tenella, which regularly causes extensive hemorrhage
and death to chickens by the thorough destruction of intestinal villus (Chapman, 2014),
hemorrhagic enteritis was noted in chickens during trial 1. It developed to the highest
level of severity at day 23. In the whole small intestine, the paleness of the mucosal
membrane that resulted from bloody diarrhea would indisputably impede the observation
of NE lesions. Accordingly, days 19 to 21 were indicated as the optimal period for NE
observation in our co-infection model. If long-term observation of NE progress is
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required, the application of multiple species of Eimeria before the C. perfringens
challenge is not recommended, especially in infections with coccidia developing in the
lower intestine, such as E. tenella.
In conclusion, the co-infection model with netB positive C. perfringens and
Eimeria combined with fishmeal feeding favorably reproduced NE in this study. In
contrast, the use of a netB positive C. perfringens without other contributory factors did
not induce NE. When more predisposing factors participated in the induction, the severity
and incidence of NE were increased. In addition, Eimeria had significant influence on the
induction of NE. In the past, the intensive focus on the netB-positive strain of C.
perfringens in NE induction has failed to guarantee the consistent experimental
reproduction of NE. The insights provided by the present study would be of value in
establishing a refined model that delivers consistent results and can be applied to study
the efficacy of novel feed additives and alternative mitigation strategies toward NE.
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Abstract
Gut microbiota has been demonstrated to be involved in intestinal nutrition,
defense, and immunity, as well as to participate in disease progression. This study was to
investigate gut microbiota changes in chickens challenged with netB-positive Clostridium
perfringens strain 1 (CP1) and/or the predisposing Eimeria species (Eimeria). In addition,
the effects of lauric acid, a medium-chain fatty acid (MCFA), on NE reduction and
modulation of microbiota were evaluated. The results demonstrated that microbial
communities in the jejunum were distinct from those in the cecum, and the microbial
community change was more significant in the jejunum. The challenge of CP1 in
conjunction with Eimeria significantly reduced species diversity in the jejunal
microbiota, but cecal microbiota remained stable. In the jejunum, CP1 challenge
increased the abundance of the genera of Clostridium sensu stricto 1, Escherichia
Shigella, and Weissella, but significantly decreased the population of Lactobacillus.
Eimeria infection on its own was unable to promote NE, demonstrating decrements of
Clostridium sensu stricto 1 and Lactobacillus. Co-infection with CP1 and Eimeria
reproduced the majority of NE lesions with a significant increment of Clostridium sensu
stricto 1 and reduction in Lactobacillus. The changes of these two taxa increased
following NE severity. Further analyses of metagenomeSeq, STAMP, and LEfSe showed
significant overgrowth of Clostridium sensu stricto 1 was associated with the NE and
Eimeria infection precedent to C. perfringens challenge has a synergistic effect on the
overrepresentation. In addition to C. perfringens, another member within Clostridium
sensu stricto 1 was found to participate in NE development. The supplementation of
lauric acid did not reduce NE incidence and severity but decreased the relative abundance
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of Escherichia Shigella. In conclusion, significant overgrowth of Clostridium sensu
stricto 1 in the jejunum is the major microbiota contributory to the NE. The controlling
proliferation of this taxon in the jejunum should be the niche for developing effective
strategies against NE.
4.1

Introduction
Necrotic enteritis (NE) as the result of proliferation of Clostridium perfringens (C.

perfringens) type A and their associated toxins in the small intestine of chickens is a
devastating enteric disease, characterized by sudden diarrhea, unexpected mortality, and
mucosal necrosis (Cooper et al., 2013; Martin and Smyth, 2009). Up to 37% of
commercial broiler flocks is estimated to be affected by this disease, and it has
contributed to the losses of 6 billion dollars in the global poultry industry (Van Der Sluis,
2000; Wade and Keyburn., 2015). In recent decades, C. perfringens-associated NE in
poultry has been well-controlled by in-feed antimicrobial growth promoters (AGPs) (Liu
et al., 2010). However, the emergence of antibiotic-resistant bacteria from animals and
the potential threat of transmission to humans has led to bans on using AGPs in many
countries (Marshall and Levy, 2011; Van Immerseel et al., 2004b). Following the
withdrawal of AGPs from poultry feed, NE has re-emerged as a significant disease to the
poultry industry (Casewell et al., 2003; Gaucher et al., 2015; Timbermont et al., 2011;
Van Immerseel et al., 2009).
Gut microbiota is one of the central defense components in the gastrointestinal
tract against enteric pathogens, which works by modulating host responses to limit the
colonization of pathogens (Rehman et al., 2007). Interactions between gut microbiota and
the host could influence the intestinal morphology, physiology, and immunity (Pan and
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Yu, 2014). Recently, gut microbiota has been demonstrated to regulate intestinal gene
expression (Yin et al., 2010) and T cell-mediated immunity (Mwangi et al., 2010) as well
as to accelerate the maturation of the gut immune system (Crhanova et al., 2011).
Conversely, a growing number of studies have observed gut microbial shifts in enteric
diseases, considering that gut microbiota plays a role in the progress of disease
development. Similar results were also represented in NE induction models, proposing
that the disturbance of gut microbiota interacts with the host, subsequently promoting the
development of NE (Feng et al., 2010; Li et al., 2017b; Stanley et al., 2012b; Stanley et
al., 2014). In the case of human necrotizing enterocolitis, an enteric disease in infants
associated with C. perfringens (Dittmar et al., 2008), a recent study found that
Bacteroides dorei, an opportunist pathogenic bacterium in anaerobic infections, was
associated with an increased mortality of this disease (Heida et al., 2016). Furthermore,
several studies have demonstrated that the increment of bacteria belonging to a genus of
Escherichia-Shigella was associated with C. perfringens infection (Li et al., 2017b; Liu et
al., 2010). This evidence raised the possibility that certain microbes or microbiota in the
gut may contribute to the virulence or development of enteric disease in chickens,
particularly for NE.
The removal of AGPs drove the poultry industry to search for an alternative in
prevention to decrease the incidence of NE. Probiotics, prebiotics, organic acids, plant
extracts, essential oils, and enzymes arose in response to this demand, but the efficacy of
those on NE reduction was variable and inconsistent (Caly et al., 2015; Dahiya et al.,
2006). However, a medium-chain fatty acid (MCFA), lauric acid, was found to have
strong in vitro antimicrobial activity against gram-positive organisms (Hermans et al.,
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2012; Van Immerseel et al., 2004a; Zeiger et al., 2017) and C. perfringens (Skrivanova et
al., 2005; Timbermont et al., 2010). In an in vivo trial, lauric acid with butyric acid
demonstrated the lowest incidence and severity of NE compared to other treatments
(Timbermont et al., 2010). However, this promising result did not promote more
applications of lauric acid against NE, and the interaction of lauric acid with gut
microbiota was not even addressed. The evaluation of its modulation effect on NE
reduction and gut microbiota simultaneously would be valuable in exploring specific
microbial community contributory to the NE.
Although C. perfringens is the causative etiological agent of NE, it is evident that
other predisposing factors are required for NE induction (Prescott et al., 2016b;
Shojadoost et al., 2012; Timbermont et al., 2011; Wu et al., 2014). Even though gut
microbiota has been suggested to be involved in the progress of NE development (Moore,
2016; Prescott et al., 2016a), the association between microbiota profile and NE
development have not been well elucidated. Most studies intensively focused on changes
of microbial communities in the ileum or in cecum where a higher quantity of microbes
or/and more diverse microbial compositions was harbored; however, most results were
inconclusive (Feng et al., 2010; Lin et al., 2017; Stanley et al., 2012b; Stanley et al.,
2014; Xu et al., 2018). Inversely, microbiota in the jejunum, which serve as the primary
site for colonization of C. perfringens and development of NE (Prescott et al., 2016a),
was seldom evaluated. In the present study, we investigated gut microbiota targeting NE
cases and in chickens with side-by-side treatments with the causative pathogen and
parasitic predisposing factor, Eimeria, and expected to unveil the contributory microbe or
microbiota to the NE. The effects of lauric acid on NE reduction and modulation of
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microbiota were also examined to confer the alternative intervention to prevent and
control NE.
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4.2
4.2.1

Materials and Methods
Chicken, diet, and experimental design
A total of 50 male and female one-day-old unvaccinated broiler chicks (Cobb

strain) were obtained from a commercial hatchery. The chicks were inspected on
receiving to ensure their healthy status and randomly allotted to 5 groups, studying the
NE incidence and gut microbiota after challenge of netB-positive C. perfringens (A
group: CP1), co-infection with netB-positive C. perfringens and multi-species Eimeria (B
group: CP1+Eimeria), addition of lauric acid to feed chickens co-infected with netBpositive C. perfringens and multi-species Eimeria (C group: CP1+Eimeria+LA),
inoculation of multi-species Eimeria (D group: Eimeria), and no treatment (E group:
CTL).
Chicks in groups were placed in separate temperature-controlled iron tanks with
nets in the floor-pen facility and lined with fresh litter. Throughout the 19-day study
period, wheat-based diets prepared based on the formula by Branton et al. (Branton et al.,
1987) were offered for the first 7 days, and then the rations were replaced by fishmeal
diets (wheat-based diets containing 50% fishmeal) obtained from the 1:1 mixture of
wheat-based diet with fishmeal 60 N (Seven Springs Farm, Check, Virginia, USA),
containing minimal 60% crude protein from days 8 until the end of the study. For the
lauric acid supplementing group, 400 mg of lauric acid powder (Fisher Scientific,
Pittsburgh, Pennsylvania, USA) was added into 1 kg of wheat-based diet or fishmeal diet
to form the final ration for chickens from day 8 onward (Timbermont et al., 2010).
Co-infection with netB-positive C. perfringens (CP1) and multi-species Eimeria
was applied to induce NE according to our previous studies. The success of reproducing
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NE was determined by clinical signs and intestinal lesion scores reaching 2 or more. In
brief, chickens in the co-infection group were given a single gavage of coccidial
inoculum at day 10, followed by oral administration of 3 ml CP1 inoculum with average
2.5x108 colony-forming units (CFU)/ml at day 15 for 4 consecutive days with a
frequency of 3 times daily. For a single challenge of CP1 or Eimeria, the same
methodology and time points were conducted as in the co-infection group. All chickens
were inspected on a daily basis and humanely euthanized at day 19 by carbon dioxide.
Dead chickens not resulting from NE were excluded from the trial after necropsy.
All procedures for the care, housing, and treatment of chickens were approved by
the Institutional Animal Care and Use Committee at Mississippi State University
(IACUC 16-439). This protocol complies with Guide for Care and Use of Laboratory
Animals, Public Health Service Policy on Human Care and Use of Laboratory Animals
and the U.S. Animal Welfare Act. Mississippi State University is accredited by the
Association for the Assessment and Accreditation of Laboratory Animal Care
International (AAALAC). All chickens were acclimated for one week prior to any
experimental procedures. Chickens had ad libitum access to water and feed and were
monitored twice daily. The death was not the endpoint of this experiment. Chickens were
humanely euthanized by CO2 inhalation when they displayed respiratory distress,
injuries, reluctant to move, or severe weight loss according to the approved protocol.
4.2.2

Challenge strain and inoculum preparation
Anticoccidial live vaccine containing live oocysts of E. acervulina, E. maxima, E.

maxima MFP, E. mivati, and E. tenella was used as a disposing factor. The vaccine bottle
contained 10,000 doses of oocysts in an unspecified proportion of Eimeria species. A
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tenfold dose of vaccine was prepared then applied on Eimeria-treated and co-infection
groups. C. perfringens, a clinical NE strain designated as CP1 obtained from Dr. John F.
Prescott (Ontario Agricultural College, University of Guelph, Canada), was used to
challenge chickens. This strain was characterized as netB-positive Type A and used to
reproduce NE in a number of experiments (Jiang et al., 2009; Thompson et al., 2006; Yu
et al., 2017; Zhou et al., 2017). CP1 was cultured on blood agar plates and incubated
anaerobically at 37°C for overnight. A single colony was in turn transferred into 3 ml of
fluid thioglycollate (FTG) medium (Himedia, Mumbai, Maharashtra, India) at 37°C for
overnight. Thereafter, the bacterial suspension was inoculated into fresh FTG broth at a
ratio of 1:10 and incubated at 37°C for 15, 19, and 23 hours, respectively. The whole
broth cultures were used to induce NE based on the evidence that clostridia with toxins
produce more severe disease than using cells alone (Thompson et al., 2006). The bacterial
concentration (CFU/ml) of inoculum was calculated by plate counting using Brain Heart
Infusion agar (Sigma-Aldrich, St. Louis, Missouri, USA), followed by anaerobic
incubation at 37°C for 16 hours.
4.2.3

Sample collection and lesion scoring
Three chickens per group were randomly selected to collect fecal contents from

the jejunum (AJ, BJ, CJ, DJ, and EJ) and cecum (AC, BC, CC, DC, and EC). Among
three CP1-challenged groups (A, B, and C), chickens suffering NE (lesion score ≥ 2)
were preferentially collected. Then, the remaining chickens were sampled randomly to
reach a quantity of 3. One percent of 2-mercaptoethanol (Sigma-Aldrich) in PBS was
used to wash fecal contents, and samples were immediately frozen at -80°C. The
intestinal tissues (duodenum to ileum) were inspected for NE lesions and scored
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following the criteria described by Keyburn (Keyburn et al., 2006), with a range of 0 (no
gross lesions), 1 (congested intestinal mucosa), 2 (small focal necrosis or ulceration; one
to five foci), 3 (focal necrosis or ulceration; 6 to 15 foci), and 4 (focal necrosis or
ulceration; 16 or more foci). Chickens with lesion scores reaching 2 or higher were
identified as NE cases, and the highest score in their small intestinal sections (duodenum,
jejunum, and ileum) was recorded as the final score of NE.
4.2.4

DNA extraction
Total genomic DNA was isolated from approximately 250 mg of fecal contents

using the MOBIO PowerFecal® DNA Isolation Kit (Mobio, Germantown, Maryland,
USA) following the manufacturer’s protocol with some modifications. After adding bead
solution and lysis buffer, the mixture was heated in a water bath at 65°C for 30 minutes
followed by 5 minutes of vortexing. The concentration and quality of harvested DNA
were determined by NanoDrop™ One Microvolume UV-Vis Spectrophotometer (Fisher
Scientific) and visualized on 0.8% agarose gel (BD Biosciences, San Jose, California,
USA). Afterward, genomic DNA was stored at -20°C until further analysis.
4.2.5

16S rRNA library preparation and sequencing
The variable V3-V4 region of the 16S rRNA gene was PCR-amplified in 25-μl

reaction mixtures, containing 12.5 μl Clontech Labs 3P CLONEAMP HIFI PCR
PREMIX (Fisher Scientific), 1 μl of each 10-μm Illumina primer (forward primer5’CCTACGGGNGGCWGCAG 3’ and reverse primer-5’
GACTACHVGGGTATCTAATCC 3’) with standard adapter sequences, and 1 μl of
DNA template. The PCR conditions started with an initial denaturation step at 95°C for 3
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minutes, followed by 25 cycles of 95°C for 30 seconds, 55°C for 30 seconds, and 72°C
for 30 seconds, and a final extension step at 72°C for 5 minutes on Applied Biosystems
GeneAmp PCR System 9700 (Applied Biosystems Inc., Foster City, California, USA).
The amplicons were cleaned up by Monarch® DNA Gel Extraction Kit (New England
Biolabs, Ipswich, Massachusetts, USA). Subsequently, an index PCR was performed by
using Nextera XT Index Kit (Illumina, San Diego, California, USA) to attach a unique 8bp barcode sequence to the adapters. The applied 25-μl reaction was composed of 12.5 μl
KAPA HiFi HotStart Ready Mix (Kapa Biosystems, Wilmington, Massachusetts, USA),
2.5μl of each index primer, and 1 μl of 16S rRNA amplicon and reaction conditions were
as follows: 95°C for 3 minutes, 8 cycles of 95°C for 30 seconds, 55°C for 30 seconds,
72°C for 30 seconds, and 72°C for 5 minutes on Mastercycler® pro (Eppendorf AG,
Hamburg, Germany). The PCR products were purified using Agencourt AMPure XP
beads (Beckman Coulter, Indianapolis, Indiana, USA), and the size and concentration
were determined by Bioanalyzer with DNA 1000 chip (Agilent, Santa Clara, California,
USA) and Qubit® 2.0 Fluorometer with Qubit™ dsDNA HS Assay Kit (Fisher
Scientific). Those libraries were normalized and pooled to one tube with the final
concentration of 10 pM. Samples were thereafter sequenced on the MiSeq® System
using Illumina MiSeq Reagent Kit v3 (2×300 bp paired-end run).
4.2.6

Sequence processing and data analysis
Paired-end sequences were merged by means of fast length adjustment of short

reads (FLASH) v1.2.11 (Magoc and Salzberg, 2011) after trimming of primer and
adapter sequences. Reads were de-multiplexed and filtered by Quantitative Insights into
Microbial Ecology (Qiime) software v1.9.1 (Caporaso et al., 2010), meeting the default
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quality criteria and a threshold phred quality score of Q ≥ 20. Chimeric sequences were
filtered out using the UCHIME algorithm (Edgar et al., 2011). The pick-up of operational
taxonomic units (OTUs) was performed at 97% similarity by the UPARSE algorithm
(Edgar, 2010) in USEARCH (Edgar, 2013). The OTUs were further subjected to the
taxonomy-based analysis by RDP Classifier v2.11 with a cut-off of 80% (Wang et al.,
2007) using the Silva v128 database. Differential abundance of OTU among treatments
was evaluated by metagenomeSeq. The clustered OTUs and taxa information were used
for diversity and statistical analyses by Qiime v1.9.1 and R package v.3.3.1
(http://www.R-project.org/). Differences of taxonomic profiles between groups were
compared using Statistical Analysis Metagenomic Profiles (STAMP) software (Parks et
al., 2014) v2.1.3 with Welch’s t-test.
Furthermore, LEfSe (linear discriminant analysis effect size) from the LEfSe tool
(http://huttenhower.sph.harvard.edu/lefse/), an algorithm for high-dimensional class
comparisons between biological conditions, was used to determine the significant feature
taxa between groups or intestinal location. It emphasizes statistical significance,
biological consistency, and effect relevance and allows researchers to identify
differentially abundant features that are also consistent with biologically meaningful
categories (Segata et al., 2011). The Kruskal-Wallis rank sum test was included in LEfSe
analysis to detect significantly different abundances and performed LDA scores to
estimate the effect size (threshold: ≥ 4).
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4.3

Results

4.3.1

NE reproduction and effects of lauric acid as an alternative prevention
Six of the NE cases were identified in three CP1-challenged groups (Table 4.1).

They showed different degrees of characteristic gross lesions in small intestinal tissues.
The most severe lesions were found in the jejunum, between its proximal end and
Meckel’s diverticulum. Under co-infection with CP1 and Eimeria, the incidence and
severity of NE increased. No NE mortality was noticed. Statistically significant
differences of lesion score (LS) were determined between three CP1-challenged groups
(A, B, and C) and the control counterpart (p ≤ 0.05). The co-infection groups (B and C)
demonstrated a highly significant difference (p ≤ 0.01). However, the supplementation of
lauric acid did not reduce the incidence and severity which were similar to the NE
positive control group.
Table 4.1

NE frequency and mean lesion score by groups

NE lesion score
NE1
Subtotal Lesion score
case2
0
1
2
3
4
A
CP1
0
9
1
0
0
10 1.11 ± 0.31a3
1
B
CP1+Eimeria
0
8
0
1
1
10 1.50 ± 1.02a*3
2
1
a*3
C
CP1+Eimeria+LA
0
7
1
1
1
10 1.60 ± 1.02
3
D
Eimeria
10
0
1
b3
E
CTL
5
4
0
0
0
9 0.44 ± 0.50
0
1
LA lauric acid; NE necrotic enteritis; CTL: control group.
2
NE case: lesion score reaching 2 or above.
3
Dissimilar letters indicate a significant difference at a level of α=0.05. * represents
highly significant p ≤ 0.01.
One chick in CTL was misplaced in the other group during the trial and excluded.
Group

Treatment
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4.3.2

Metadata and sequencing
A total of 11,191,102 sequence reads with an average length of 453 ±5 base pairs

were obtained from 30 samples, including 15 jejunal samples (3 samples per group in AJ,
BJ, CJ, DJ, and EJ) and 15 cecal samples (3 samples per group in AC, BC, CC, DC, and
EC). The sequences were filtered and further clustered into OTU using a cut-off of 97%
similarity. The estimate of Good’s coverage reached 98% for all the jejunal and cecal
samples. The rarefaction curve demonstrated that the sequencing depth was adequate to
cover the bacterial diversity in the jejunal and cecal samples (Figure 4.1).

Figure 4.1

Rarefaction curve of OTUs in jejunal and cecal samples.

The curve demonstrated that all samples approximately reached asymptotes, indicating
that deeper sequencing would only represent rare additional taxa.
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4.3.3

Normal microbial composition in the jejunum and cecum
Firmicutes (92.1% of relative abundance) was the most dominant phylum in the

jejunum, followed by Cyanobacteria (2.2%) and Proteobacteria (2.1%), Bacteroidetes
(1.9%), and Actinobacteria (1.7%). On the contrary, the phylum of Bacteroidetes
(75.5%) predominated in the cecum, followed by Firmicutes (19.8%) and Proteobacteria
(4.7%) (Figure 4.2A). At the genus level, jejunal contents were dominated by
Lactobacillus (41.2% of relative abundance) and Clostridium sensu stricto 1 (39.1%),
followed by other unclassified genus (8.7%), Weissella (3.6%), Enterococcus (1.9%),
Escherichia Shigella (1.8%), and Staphylococcus (1.6%). Bacteroides (75.5%) was the
most abundant genus in the cecum, followed by other unclassified genus (17.2%),
Escherichia Shigella (3.1%), Eisenbergiella (1.7%), and Anaerotruncus (1.5%) (Figure
4.2B). The genera of Lactobacillus, Clostridium sensu stricto 1, Weissella, Enterococcus,
Staphylococcus, and Bifidobacterium in the jejunum exhibited significant difference in
abundance compared to those in the cecum. Cecal microbiota contained significantly
higher abundances of Bacteroides and Proteus (Welch’s t test, p < 0.05; Figure 4.3).
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Figure 4.2

Microbial compositions in the jejunum and cecum with different
treatments.

Each bar represents the average relative abundance of each bacterial taxon within a
group. Microbial compositions in jejunal and cecal groups at the level of the phylum (A)
and genus (B). Microbial compositions in jejunal and cecal samples at the genus level
(C). LS stands for lesion score of NE. The top 5 and 10 abundant taxa are shown at the
level of phylum and genus, respectively.
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Figure 4.3

Differential abundant taxa at the genus level between jejunal and cecal
microbiota in control chickens by STAMP with Welch's t-test.

The differential genus was assigned only to those presenting a minimum variation at a
significant level (p < 0.05).

4.3.4

Changes of microbial communities in response to treatments
In the jejunum, the challenge of CP1 increased the relative abundance of the

genera of Clostridium sensu stricto 1 (54.75%), Escherichia Shigella (9.57%), and
Weissella (4.99%) but significantly decreased the population of Lactobacillus (25.44%)
(Figure 4.4). The inoculation of Eimeria to chickens significantly increased the relative
abundance of Weissella (16.01%) and Staphylococcus (6.51%) but decreased the amount
of Lactobacillus (30.66%) and Clostridium sensu stricto 1 (27.69%). Co-infection with
CP1 and Eimeria led to the significant increment of Clostridium sensu stricto 1 (71.89%),
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increased relative abundance of Escherichia Shigella (4.68%), but the decrements of
Lactobacillus (16.99%), Weissella (0.44%) and Staphylococcus (0.40%). In the cecum,
different treatments did not promote significant difference of taxa abundance between
groups with an exception of Eisenbergiella, significantly increased in the co-infection
group. However, the challenge of CP1 and co-infection of CP1 and Eimeria still
promoted cecal increments of Clostridium sensu stricto 1 (the relative abundance of this
taxon in groups challenging with CP1, CP1 and Eimeria, and control was 0.75%, 1.99%,
and 0.02%).
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Figure 4.4

Differential abundance of genera between groups in the jejunum and cecum
by metagenomeSeq.

(A) Lactobacillus; (B) Clostridium sensu stricto 1; (C) Weissella; (D) Staphylococcus;
(E) Escherichia shigella; (F) Eisenbergiella. * p ≤ 0.05 and ** p ≤ 0.01.
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4.3.5

Microbial diversities in response to treatments
In jejunal microbiota, the challenge of CP1 (AJ) and co-infection with CP1 and

Eimeria (BJ) reduced species richness and evenness, but the infection of Eimeria (DJ)
exerted counter results. The addition of lauric acid into the co-infected group (CJ)
exacerbated the reduction observed in BJ group. However, no apparent effect was noted
on cecal microbiota following above treatments (Figure 4.5 and Figure 4.6). Analysis of
alpha diversity by Shannon index further demonstrated that the challenge of CP1 in
conjunction with Eimeria infection significantly reduced species diversity in jejunal
microbiota. The 16S rRNA gene survey by principal coordinate analysis (PCoA) and
principal component analysis (PCA) showed a distinct separation of two community
profiles between the jejunal and cecal microbiota. Cluster and heat map analyses
exhibited distinct classifications and microbial compositions between the jejunum and
cecum, coinciding with observations on PCoA and PCA (Figure 4.7). Additionally, the
results of PCoA and PCA also depicted the differential diversity between the CP1challenged (group AJ, BJ, and CJ), Eimeria-infected (DJ), and control (EJ) groups in the
jejunal microbiota, showing that the challenge of CP1 shared similar microbial
community structures with co-infection with CP1 and Eimeria. However, cecal groups
with CP1 treatments did not display cluster phenomenon as jejunal groups displayed in
PCoA. PCA with hierarchical clustering further reflected that Clostridium sensu stricto 1
was contributory to the similarity of NE assemblage, and the genera of Lactobacillus,
Weissella, and Staphylococcus contributed to discrepant community structures in
Eimeria-treated and control groups in the jejunum. On the other hand, Bacteroidetes was
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the main genus contributing to the distinct separation between jejunal and cecal groups
(Figure 4.8).

Figure 4.5

Rank abundance curve represented by groups.

The total number of species is presented in the maximum reading of each curve on the xaxis, while values on the y-axis indicate the relative abundance of each ranked species.
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Figure 4.6

Alpha diversity analysis between groups in the jejunum and cecum.

(A) Shannon index, (B) Simpson index (C) Abundance-based Coverage Estimator (ACE)
index, and (D) Chao1 index. Results are shown as mean ± SEM. Kruskal-Wallis test: * p
≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001.
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Figure 4.7

Comparison of microbial community profiles and similarities between
jejunal and cecal groups with different treatments.

(A) Weighted unifrac principal coordinate analysis (PCoA); (B) principal component
analysis (PCA); (C) cluster analysis by the unweighted paired-group method using
arithmetic means (UPGMA) using unweighted unifrac distance; (D) heat map analysis at
the level of genus.
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Figure 4.8

Contributory genera to NE assemblage and dissimilarity between groups by
principal component analysis with hierarchical clustering.

All NE cases were clustered as NE assemblage in the red circles.

4.3.6

Microbial community structure and taxa contributory to NE
Analysis of jejunal microbiota in NE cases revealed that Clostridium sensu stricto

1, to which causative C. perfringens belongs, was the most dominant genus, followed by
Lactobacillus, Weissella, Escherichia Shigella, Staphylococcus, and others.
Accompanying the elevation of NE severity, the relative abundance of Clostridium sensu
stricto 1 increased (relative abundance ≥ 75% in LS4 compared to 50-75% in LS2 and
LS3). Conversely, the population of Lactobacillus decreased while the lesion score was
elevated. The relative amount of Escherichia Shigella was variable in NE cases,
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presenting a higher abundance after CP1 challenge but low population following coinfection with CP1 and Eimeria. (Figure 4.2C).
Heat map analysis exhibited that NE cases harbored the similar microbial
community profile. Clostridium sensu stricto 1 and C. perfringens were consistently
presented and abundant taxa in the jejunum (Figure 4.9). Opposite low abundance of
Lactobacillus was noted. However, only the increment of Clostridium sensu stricto 1 but
not C. perfringens (data not shown) demonstrated significance on NE by metagenomeSeq
(Figure 4.4B). Using Welch's t-test, jejunal groups further showed that CP1 in
conjunction with Eimeria increased significantly Clostridium sensu stricto 1 and C.
perfringens when compared to the control (Figure 4.10 and Figure 4.11; p < 0.05),
whereas challenge of CP1 alone did not lead to significant increase of these taxa.
Differential abundant taxa between different treatments in jejunum were further evaluated
by LEfSe using the LDA score of 4. This threshold guarantees that the meaningful taxa
are compared and eliminates most of rare taxa. LEfSe demonstrated similar results as the
Welch’s test that the challenge of CP1 unable to yield a significantly higher amount of
Clostridium sensu stricto 1 and C. perfringens. However, significant differences were
displayed when CP1 co-infected with Eimeria (Figure 4.12). No differential taxon was
found in cecal groups (AC, BC, CC, DC, and EC) while Welch's t-test and LEfSe were
applied.
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Figure 4.9

Heat map analysis of contributory taxa to NE.

The heat map is demonstrated at the level of genus in jejunal (A) and cecal (B) samples.
Analysis of gut bacteria with the relative abundance of OTUS by z score (C) represents
bacterial taxa information, including phylum, family, genus, and species. This analysis
showed the increment of Clostridium sensu stricto 1 and C. perfringens, as well as the
decrement of Lactobacillus followed NE severity in the jejunum.
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Figure 4.10

Deferential taxa between treatments and control group at the genus level by
STAMP with Welch's t-test.

(A) Comparison between AJ and EJ, (B) BJ and EJ, and (C) CJ and EJ groups. The
differential genera were assigned only to those presenting a minimum variation at a
significant level (p < 0.05).
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Figure 4.11

Deferential taxa between treatments and control group at the species level
by STAMP with Welch's t-test.

(A) Comparison between AJ and EJ, (B) BJ and EJ, and (C) CJ and EJ groups. The
differential species were assigned only to those presenting a minimum variation at a
significant level (p < 0.05).
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Figure 4.12

LEfSe analysis of differentially abundant clades at all taxonomic levels
between CP1-challenged and control groups in jejunal microbiota.

LEfSe identified the most differentially abundant clades between groups using the LDA
score of 4. Differentially abundant taxa in group BJ versus EJ (A), and CJ versus EJ (B).
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4.3.7

Comparison of gut metagenomes in co-infected chickens with and without
lauric acid
The addition of lauric acid increased the relative abundance of Clostridium sensu

stricto 1 and Weissella but decreased the relative amount of Lactobacillus and
Escherichia Shigella in the jejunum compared to the co-infection group without
supplementing lauric acid. Nonetheless, no significance was detected in this comparison.
In addition, supplementation of lauric acid did not apparently affect the cecal microbiota
between these two groups.
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4.4

Discussion
By exploring microbial composition in normal chickens, the major microbial

genera in the jejunum were Lactobacillus and Clostridium sensu stricto 1, followed by
other unclassified bacteria, Weissella, Enterococcus, Escherichia Shigella, and
Staphylococcus. Bacteroides was the most abundant group in the cecum, and the
remaining taxa were sequentially other unclassified bacteria, Escherichia Shigella,
Eisenbergiella, and Anaerotruncus. Side by side treatments of C. perfringens and
Eimeria altered microbial community compositions, significantly in jejunal microbiota.
In this study, the challenge of CP1 increased the abundance of Clostridium sensu stricto
1, Escherichia Shigella, and Weissella in the jejunum, but significantly decreased the
population of Lactobacillus. Infection of Eimeria significantly increased the abundance
of Weissella and Staphylococcus but decreased the amount of Lactobacillus and
Clostridium sensu stricto 1. Co-infection with C. perfringens and Eimeria led to the
significant increment of Clostridium sensu stricto 1, increased the abundance of
Escherichia Shigella, but decrements of Lactobacillus, Weissella, and Staphylococcus.
Specifically, it decreases the α-diversity index of the small intestinal microbial
community, promoting the single dominance of Clostridium sensu stricto 1 reaching the
relative abundance to 71.89%. On the other hand, six NE cases shared similar microbial
community profile observed in PCA, indicating there exists a certain microbiota
contributory to the disease. With more NE severity, the higher relative abundance of
Clostridium sensu stricto 1 but the lower relative amount of Lactobacillus in jejunal
microbiota was noted.
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Several studies have been shown C. perfringens challenge decreased the
population of Lactobacillus in the ileum (Antonissen et al., 2016; Li et al., 2017b).
Lactobacilli are known as lactic acid-producing bacteria and shown to have protection at
the intestinal barrier by competition with pathogens. They are also able to induce
immunomodulation and ferment carbohydrates into lactic acids that lower the pH of the
intestinal environment to inhibit the growth of acid-sensitive pathogenic bacteria
(Belenguer et al., 2007; Sengupta et al., 2013). Therefore, suppression of lactobacilli is
regularly considered beneficial to the growth and colonization of enteric pathogen. This
study first demonstrated the decrement of lactobacilli in jejunum following challenge of
C. perfringens alone and in conjunction with Eimeria. The change of this taxon following
the NE severity indicates that the decrement of Lactobacillus may play a role in the
development of NE. In addition, the increased abundance of Escherichia Shigella was
also observed after the challenge of C. perfringens and co-infection with C. perfringens
and Eimeria. This genus includes enteric pathogens, which can colonize in the intestines
of both humans and chickens, consequently triggering specific diseases (Mora et al.,
2010). Some studies indicated that the increment of Escherichia Shigella in ileum was
correlated with NE (Du et al., 2015; Du et al., 2016). Nevertheless, our study found that
C. perfringens challenge could increase the abundance of Escherichia Shigella, but the
increment was not in accordance with NE occurrence. Furthermore, the reduction of this
taxa abundance was noticed in lauric acid supplementing group which has the highest
number of NE cases. Those finding reflected a contradiction for this genus participating
in NE development. Last but not least, a reduced abundance of Weissella in the jejunum
of NE afflicted chickens was also noted. Another study reported similar results in cecal
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microbiota after C. perfringens challenge (Stanley et al., 2012b). Weissella is a lactic acid
bacterium and belongs to the family of the Leuconostocaceae. They harbor probiotic
properties and can generate several products with probiotics potential (Fusco et al.,
2015). It may interact with C. perfringens as other lactic acid bacteria, but its role in NE
development is unclear. More studies will be needed to elucidate the relationship between
Weissella and NE.
In the current study, significant overgrowth of Clostridium sensu stricto 1 was
associated with the NE and the infection of Eimeria precedent to C. perfringens challenge
exerted synergistic effects on the overrepresentation. This correlation was consistently
demonstrated by analyses of metagenomeSeq, STAMP, and LEfSe. The STAMP and
LEfSe further showed C. perfringens was significantly overrepresented in NE groups.
However, such significance was not identified by metagenomeSeq when C. perfringens
was targeted. This result indicates that, in addition to C. perfringens, another member
under the same genus of Clostridium sensu stricto 1 also played a role in contributing to
the development of the disease. The Clostridium genus is well-classified into 19 clusters
by phylogenetic analysis (Collins et al., 1994). Clostridium sensu stricto are grouped
around the type species Clostridium butyricum and belong to the Clostridium cluster
1within the Clostridiaceae family (Stackebrandt et al., 1999). Clostridium sensu stricto 1
contains C. perfringens and other real Clostridium species. Their members are generally
perceived as pathogenic (Rajilic-Stojanovic and de Vos, 2014) as well as interpreted as
an indicator of a less healthy microbiota (Lakshminarayanan et al., 2013). This
suggestion coincides with our finding that C. perfringens challenge on its own is not
capable of causing a significant abundance of Clostridium sensu stricto 1 and unable to
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produce more NE case observed. Future research is recommended to clarify the role of
other members of Clostridium sensu stricto 1 in the pathogenesis of NE.
Single infection of Eimeria could not produce NE in the present study. The
treatment reduced the relative abundance of Clostridium sensu stricto 1 and Lactobacillus
but significantly increased Weissella and Staphylococcus in jejunal microbiota. Eimeria
infection has been shown to provide nutrients for C. perfringens to grow and cause
physical damage to gut epithelium, thus facilitating the colonization and proliferation of
C. perfringens (Van Immerseel et al., 2009; Williams, 2005; Williams et al., 2003).
However, the inoculation of Eimeria into normal chickens did not elicit overgrowth of
Clostridium sensu stricto 1 and C. perfringens except challenging with exogenous C.
perfringens. In contrast, the challenge of C. perfringens alone and in conjunction with
Eimeria both promote proliferation of Clostridium sensu stricto 1 and NE case. This
indicates that the amount of commensal C. perfringens in the jejunum under Eimeria
infection is not sufficient to reach the significant abundance of Clostridium sensu stricto
1 or C. perfringens, subsequently promoting the occurrence of NE. Therefore, it is
reasonable to suggest that the quantity of C. perfringens reaching a certain level in the
jejunum is critical for the onset of proliferation. A recent study used commensal C.
perfringens, the isolate from normal chicken, to challenge broiler and reproduce NE in
conjunction with infection of E. maxima (Li et al., 2017a). This result also highlighted
that not the specific C. perfringens strain, but the exogenous addition of C. perfringens
played the key in achieving the consequence. Accordingly, the methodology to inhibit the
overgrowth of Clostridium sensu stricto 1 or C. perfringens in small intestines will be the
straightforward strategy to prevent NE.
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Recent studies have been shown that cecal microbiota had a prominent role in
feed efficiency (Yan et al., 2017) and received increasing attention in terms of diseases
(Wohlgemuth et al., 2011) and metabolism (Stanley et al., 2012a). In this study, the result
of PCoA and PCA demonstrated that microbial communities in the jejunum were
different from those in the cecum. Side by side treatments of C. perfringens and Eimeria
promoted microbial shifts with biological significance in the jejunum but minimal
fluctuations in taxa abundance in the cecum. Comparatively, jejunal microbiota was more
significant than cecal microbiota to address the characteristic gut microbiota contributory
to NE by means of metagenomeSeq and LEfSe analysis. The reason might be that cecal
microbiota is demonstrated more diverse than other intestinal sections (Xiao et al., 2017)
and inhibits higher amounts of microbes (1010-1011 CFU/g) than those in the jejunum
(108-109 CFU/g) (Yeoman et al., 2012). Those may provide the buffer effect on microbial
changes in cecal microbiota. Besides, preferential colonization of C. perfringens on the
mucosa of the small intestine (Prescott et al., 2016a) may also contribute to less amount
of C. perfringens into the cecum, hence adverse to elicit significant changes in cecal
microbiota.
Medium-chain fatty acids (MCFAs) such as lauric acid are a family of saturated
6- to 12-carbon fatty acids from plants and documented beneficial effects on intestinal
health and microbial growth inhibition (Bertevello et al., 2012; Dierick et al., 2004;
Zentek et al., 2012). The mechanism of their bactericidal activity is not fully understood.
Relative studies showed that they could act as nonionic surfactants to become
incorporated into the bacterial cell membrane, as well as diffuse through cell membranes
and create pores, changing membrane permeability and leading to cell death (Altieri et
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al., 2009; Bergsson et al., 2001; Desbois and Smith, 2010). In this work, lauric acid
attracted interest due to its inexpensiveness and natural properties, including strong
antibacterial effects against C. perfringens and no inhibitory effect on Eimeria infection
(Mathis et al., 2018). Based on Timbermont’s study, lauric acid was most effective in
inhibiting the growth of C. perfringens strain in vitro. Given a supplementary dose of 0.4
kg/ton in feed caused a significant decrease in NE incidence (from 50% down to 25%)
compared with the infected, untreated control group (Timbermont et al., 2010). This
study followed the dose and used experimental grade product of lauric acid to evaluate
the effects on NE incidence and intestinal microbiota. However, the addition of lauric
acid did not reduce the incidence of NE. For intestinal microbiota, lauric acid neither
exerted the inhibitory effect against the proliferation of C. perfringens nor elevated the
level of beneficial bacteria, such as Lactobacillus and Bifidobacterium. But, the relative
abundance of Escherichia Shigella was decreased without affecting the incidence. Since
lauric acid has different grade of products, such as experimental or food grade, the
contradictory result may attribute to the influence of different formula on the absorptive
efficiency of this compound. MCFAs are hydrophobic and partly absorbed through the
stomach mucosa. Hence, their triacylglycerols are considered as a desirable formula for
feed additive because they can be absorbed intact into intestinal epithelial enterocytes via
this form (Zentek et al., 2011).
In summary, significant overgrowth of Clostridium sensu stricto 1 in jejunum was
recognized as the major microbiota contributory to the NE. In addition to C. perfringens,
the other member within Clostridium sensu stricto 1 was also found to participate in
disease development. The decrement of Lactobacillus following the NE severity
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indicated that lactobacilli also participate in the progress of the disease. These taxa
showed counteractive effects in their functions as well as in the bacterial abundance,
attempting to maintain the homeostasis of jejunal microbiota in chickens. Therefore,
manipulations to inhibit multiplication of Clostridium sensu stricto 1 and C. perfringens
and to rehabilitate the dominant Lactobacillus population in the jejunum should be the
niche for developing effective strategies to prevent NE.
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CHAPTER V
CONCLUSION
NE reaches economic significance to the poultry industry because of its acute
mortality and subclinical infections in broiler flocks. After phasing out of antibiotics in
poultry production, it becomes a continuous burden to the industry worldwide without a
prompt and effective strategy to prevent and control this disease. The review of the
literature demonstrated that NE is a multifactorial disease, involving in the participation
of C. perfringens, contributory factors, and host responses. It is evident that contributory
factors create environmental conditions favorable for colonization and multiplication of
C. perfringens that predispose chickens to the disease. In addition, causative C.
perfringens produces virulent proteins such as attachment factors, collagenolytic
enzymes, bacteriocins, and toxins to promote bacterial colonization, single dominance,
invasion, and then the transmission. The host immune status, physiological integrity of
the intestines, and gut microbiota also participate in the development and severity of NE.
Although advances in NE research have greatly contributed to identifying predisposing
factors and preventative resources, including vaccines, feed additives, and others,
desirable protection or prevention strategies are still lacking. To provide practical insights
in preventing and controlling NE, this dissertation addressed several knowledge gaps in
the pathogenesis and disease induction, then generated the following conclusion.
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A novel qPCR primer set targeting netB, mainly recognized in NE-producing C.
perfringens and demonstrated as a key virulence factor for NE, was developed and
optimized to qualify and quantify this gene in C. perfringens isolated from NE and nonNE chickens. Sixty percent of NE and non-NE isolates both carried netB and no
significant difference was detected between these two types of isolates regarding the
carriage and the quantity of this gene. These results suggest that the presence and the
copy number of netB in C. perfringens are not the determinants for clinical NE.
Moreover, no significant difference was identified between NE and non-NE isolates in
the carriage of other toxin genes, cpb2, and tpeL. We conclude that netB exists in the
majority of C. perfringens type A isolates. The presence as well as the quantity of netB
are insufﬁcient to predict an association with the outbreaks of NE or the pathogenicity of
C. perfringens. Although netB has been demonstrated to fulfill molecular Koch’s
postulates in experimental models, the virulence of netB may be in effect under certain
conditions that are met, further promoting the development of NE.
NE is not similar to other clostridial diseases, regularly depending on their
secreted toxins to develop the disease. It is a multifactorial disease, and we further
demonstrated that the use of netB-positive C. perfringens without a predisposing factor
failed to induce NE in the C. perfringens and Eimeria side by side induction model. At
least one of the predisposing factors was required for the induction of disease.
Incorporation of fishmeal in conjunction with the challenge of netB-positive strain
reproduced NE but did not significantly affect the incidence of the disease. However,
chickens challenged with Eimeria and C. perfringens and fed with the diet containing
fishmeal were more susceptible to the NE and the severity of disease increased. As the
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result, we conclude that both netB-positive C. perfringens and predisposing factor(s)
were required for NE reproduction. In addition, with more predisposing factors
participating in the induction, the severity and incidence of NE increased.
We investigated gut microbiota in NE-positive and NE-negative jejunal and cecal
samples collected from a side by side C. perfringens and Eimeria challenge model. Our
results demonstrated microbial shifts with biological significance in the jejunum but
minimal fluctuations in taxa abundance in the cecum. Jejunal microbiota was shown
more significant than cecal microbiota to address characteristic gut microbiota related to
the NE. The majority of NE cases shared similar microbial community profile, presenting
a higher abundance of Clostridium sensu stricto 1, the genus contains C. perfringens, but
the relatively low amount of Lactobacillus in jejunal microbiota. With more NE severity,
the degree of changes in their abundance increased. Although lauric acid was applied in
the feed as an alternative prevention for its antibacterial effects against C. perfringens,
given a supplementary dose of 0.4 kg/ton neither exerted the inhibitory effect on the
abundance of Clostridium sensu stricto 1 nor reduced the incidence and severity of NE.
Analyses of metagenomeSeq, STAMP, and LEfSe further displayed that significant
overgrowth of Clostridium sensu stricto 1 was associated with the NE and Eimeria
infection precedent to C. perfringens challenge exerted synergistic effects on the
overrepresentation. In addition to C. perfringens, the other member under Clostridium
sensu stricto 1 was correlated to disease development. Therefore, we conclude that
significant overgrowth of Clostridium sensu stricto 1 in jejunum was the major
microbiota contributory to the NE. Besides, the decrement of Lactobacillus following the
NE severity also indicated that lactobacilli participate in the progress of the disease. The
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observation that commensal C. perfringens under Eimeria infection without challenging
exogenous C. perfringens did not reach the significant abundance of Clostridium sensu
stricto 1 and unable to promote NE. It suggests that the quantity of C. perfringens
reaching a certain level in jejunum is critical for the onset of proliferation.
In summary, the projects included in this dissertation have demonstrated that the
carriage and quantity of toxin gene are not directly correlated with the pathogenicity of
NE. Under certain condition, regulatory mechanisms may trigger the expression of
virulence genes into effect and further investigations are needed to illustrate the detailed
pathogenesis. For disease induction, both causative C. perfringens and predisposing
factor(s) are required for consistent reproduction of the disease, and Eimeria exerts
significant effects on NE induction. Fishmeal and Eimeria can act synergistically to
promote a contributory microbiota, exhibiting significant overgrowth of Clostridium
sensu stricto 1 in jejunum, under the introduction of exogenous C. perfringens, in turn
contributing to NE development in the hosts. Therefore, the measures to inhibit overproliferation of Clostridium sensu stricto 1 and C. perfringens in small intestines will be
practical to prevent NE. Based on our findings, multi-techniques including farm
sanitation, coccidial control, and optimized feed formula are recommended in the field to
avoid introducing causative pathogen and creating a favorable gut condition for
overgrowth of Clostridium sensu stricto 1 and C. perfringens.
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